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ABSTRACT
The dynamic nature of proteins in solution is often an indispensable factor in
biological function such as enzymatic catalysis. Complementary to the conventional
structural analysis, computational simulations have the advantage to reflect the dynamic
nature of proteins or enzymes. One of the computational simulation methods, the
quantum mechanical/molecular mechanical (QM/MM) molecular dynamics (MD)
simulations, has been widely applied to the research in structural analysis, ligand-receptor
binding and enzymatic catalysis.
In this dissertation, QM/MM MD simulations were applied to the studies on
cytidine deaminase (CDA), yeast cytosine deaminase (yCD), and kumamolisin-As, as
well as two protein lysine methyltransferases (PKMTs), DIM-5 and SET7/9. In the
simulations of the transition state analogue (TSA) binding of zebularine 3, 4-hydrate to
CDA and of 4-[R]-hydroxyl-3,4-dihydropyrimidine (DHP) to yCD, proton transfers were
observed between the TSA and a catalytic Glu residue in both cases. Such general acidbase mechanism was also observed in the stabilization of the tetrahedral intermediate by
a critical Asp residue during the acylation of kumamolisin-As. Moreover, dynamic
substrate-assisted catalysis (DSAC) involving the His of the substrate at P1 site was
proposed. It was suggested that DSAC may contribute to the transition state stabilizations
and substrate specificity of kumamolisin-As. The origin of the product specificities of
PKMTs was studied by comparison of QM/MM MD simulations on the first, second and
third methyl transfers in the trimethylase DIM5 and the monomethylase SET7/9. The

v
product specificities of the enzymes can be well explained by population distributions of
well-aligned reactive structures and the relative free energy barriers for the methyl
transfers. The structural and energetic reasons for the product specificities were discussed
and a triplet code based on the relative free energy barriers for the three methyl transfers
was proposed in the determination of product specificities of PKMTs.
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General Introduction
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Background
Dyanmics feature of Enzymes
Enzymes are one of the major foci of biochemical studies because of their
amazing ability in reaction rate enhancement, as high as 1020 times, 1 and high specificity,
both for the substrates and the products. It has been realized that the structures of
enzymes are critical to their activities since the crystal of urease by James Sumner in
1926. 2 In 1965, the X-ray structure of lysozyme by David Phillips et al. made it possible
for direct strcutrural analyses on the function of enzymes.

3

However, enzymes are far

beyond rigid and static structures, which were generally identified by the X-ray
crystallography method. With the developments in nuclear magnetic resonance (NMR)
and other techniques, the dynamic feature of enzymes is becoming better appreciated.
The flexibility of enzyme structures has been pointed out in the famous “induce
fit” hypotheis by Koshland 50 years ago, 4 in which substantial conformational changes
are induced by substrate binding from the apo-enzyme to the enzyme-substrate (ES)
complex (or Michaelis complex, MC)5. Recently, growing evidence from NMR
expriments confirmed the existence of the dynamic conformational ensembles of
ubiquitin and calmodulin,

6-8

which support the “conformational selection” model for

protein binding. In this model, the ligand (or substrate) binding to a protein (or enzyme)
shifts the dynamic equilibrium of the protein’s conformational ensemble in favor of the
unbound structure to the ensemble with the bound structure most populated.
recognition of the importance of dynamic features in enzymatic catalysis

11

9, 10

The

has been

boosted by the developments in new methods, such as computational simulations.
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How enzymes work
The catalytic proficicency and specificity of enzymes may involve multiple
factors,

11

which may be classified into TS-theories and MC-theories,

5

based on their

functions in transition state (TS) stabilization and substrate preorganization, respectively.
As early as 1946, Linus Pauling attributed the efficiency of enzymatic catalysis to
the ability of enzymes to stabilize transition state and lower the activation barriers of the
reactions.

5, 12

(Figure I-1) Searching for the origin of the transition state stabilization in

enzyme catalyzed reactions is one of the major foci in studying the catalytic mechanisms.
It is believed that the structure of transition state analogs (TSAs) may partially mimic the
altered structure of the substrate at transition state during the enzyme-catalyzed reaction
and capture a part of the transition state stabilization. The interactions with the TSA at the
active site may be similar to the interactions responsible for the transition state
stabilization during the catalysis.13-20 Therefore, it is possible to utilize the abundant highresolution crystallographic structures of enzyme-TSA complexes

21, 22

in computational

simulations and to obtain important insights into the catalytic power of the enzymes.
As in Figure I-1, given the energy of the transition state complex, the activation
energy may also be determined by the binding energy in the formation of Michaelis
complex (ES). This energy may have contributions from the reorganization of the
substrate structure in the active site of the reactant complex ES. Computer simulations
can be useful in understanding of related questions. For instance, in Chapter VII
computational methods are used to monitor the geometrical parameters between the
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substate and the cofactors and to explain the product specificities of protein lysine
methyltransferases (PKMTs) and their mutants.

General acid-base catalysis
General acid-base catalysis involving proton transfers may be one of the most
significant mechanisms in enzymatic catalysis.23-26 Unfortunately, the possible proton
transfers in a catalytic process or in an inhibitor binding are often neglected by the studies
of static structures, due to the invisibility of protons in high resolution X-ray structures.
On the other hand, it is possible to trace the microscopic positions of protons in
computational simulations. In simulations, the proton transfers can be observed both in
enzymatic catalysis and in the binding of a TSA at the active site.27-32
For example, in the X-ray structure of CDA-ZEB-H2O complex (PDB code:
1CTU), the presumed hydroxyl group has an abnormal longer C4-O4 bond of 1.6Å with
C4 and an unexpected low barrier hydrogen bond of 2.5Å with Oε1 of Glu104, even with a
restraint of 1.43 Å for C4-O4 bond and a restraint of 2.8Å for the O4…Oε1 distance during
the refinement. (Figure I-2) Computer simulations allowed us to observe the proton
transfer from O4 to Glu104, leading a more stable structure with the normal C4-O4 bond
of 1.5Å and the normal hydrogen bond of O4…H- Oε1 as 2.7Å.

31

In addition to

identification of proton motions in MD simulations, it is possible to quantitatively
calculate the free energy change as a result of the stabilizations by the general acid-base
mechanism33-36.
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Gene-directed enzyme prodrug therapy (GDEPT)
The gene-directed enzyme/prodrug therapy delivers a DNA construct containg an
enzyme encoding gene to target cancer cells. The enzyme expressed from this gene
generally has no toxic effect itself, but it can convert a nontoxic compound (termed as
prodrug) into a cytoxic drug. It is suggested that this reaction should be different from
endogenous pathways so as to avoid cytoxic activation in normal tissues. To ensure a
therapeutic effect, the drug should have more than 100 fold higher toxicity than the
prodrug. What is more, a proper half-life is required for the drugs to allow the diffusion
into surrounding untransfected cells, killing them by the bystander effect. However, the
drug in ciculation system must be inactive so as not to kill normal cells. 37 (Figure I-3)
The cytosine deaminase (CD)/5-fluorocytosine (5-FC) system is one of the
promising protocol for GDEPT. In this protocol, the enzyme CD is a hydrolytic
deaminase converting cytosine to uracil; this enzyme is only found in some bacteria and
fungi but not in mammalian cells. It can also convert the nontoxic prodrug 5-FC into an
anticancer drug, 5-fluorouracil (5-FU). This toxic nucleotide analogue can be converted
by normal cellular enzymes into three possible products, 5-fluorodeoxyuridine-5monophosphate (5-FdUMP), 5-fluorodeoxyuridine-5-triphosphate (5-FdUTP), and 5fluorouridine-5-triphosphate (5-FUTP), which may lead to inhibition of thymidylate
synthase, formation of 5-FU RNA and formation of 5-FU DNA, and lead to cell death. 3739

The strong bystander effect of the CD/5-FC system allows lower transfection

efficiency of the CD gene. The requirement for prodrug dose has also been lowered by
using yeast cytosine deaminase (yCD) from Saccharomyces cerevisiae, which has a 22-
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fold lower Km for 5-FC than bacteria cytosine deaminase (bCD) from E. Coli.

40

Extensive experiments have proved the CD/5-FC system to be useful in killing tumor
cells, such as breast cancer, liver cancer, colorectal carcinoma and colon carcinoma. 41-44
A number of protocols using this system are in development, including clinic trials in
USA and UK.37 To understand the role of proton transfers in the yCD-catalyzed
deamination and substrate/inhibitor binding by computational simulations is quite
interesting and may contribute to the development of therapeutical approaches and drug
design.

Proposed catalytic mechanism of Sedolisin family
The serine-carboxyl peptidases (sedolisins) family has a wide variety of sources,
such as archaea, bacteria, molds, slime molds (mixomycetes), amoebas, fishes, and
mammals. Although much larger in size, sedolisins are preseumed to have a common
ancestor with the classical serine peptidases (subtilisins). The sequence alignment of
some sedolisin members revealed four totally conserved residues, including the possible
catalytic triad Ser-Glu-Asp and an Asp that may contribute to tetrahedral intermediate
stabilization.45 (Figure I-4) The structural fold of these four residues is quite comparable
to the catalytic triad Ser-His-Asp and Asn155 in subtilisins. Based on the well-known
ping-pong mechanism of classical serine peptidases, the catalytic mechanim of sedolisin
family has also been proposed. (Figure I-5) The whole reaction circle can be separated
into acylation (left part) and deacylation (right). Each section has a substrate bound at the
beginning and a product released at the end. The product release in each section is
required to allow the binding of the substrate of the next section. During the acylation,
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the serine residue is the catalytic nucleophile to attack the substate peptide bond. The Glu
nearby seems to act as the general base to accept the proton from Ser at the time of the
nucleophilic attack, and then act as the general acid to protonate the nitrogen forming the
leaving N-terminal group. During the deacylation, this Glu still act as the general acidbase to accept a proton from the attacking water molecule and give it back to the
deprotonated Ser of the acyl-enzyme. (Figure I-5)
Although the catalytic mechanism of sedolisins and subtilisins are proposed to
have many common features, there are two major differences between them. One
difference is that in sedolisins, the Glu takes the place of the His in subtilisins to work as
the general acid-based to mediate proton transfers from the nucleophile Ser to the Nterminal of the scissile peptide bond and from the attacking water molecule back to the
deprotonated Ser in the acyl-enzyme. The other important difference is the mechanism of
the tetrahedral intermediate stabilization. In sedolisins, the Asp may act as a general acid
to protonate the tetrahedral intermediate, whereas the corresponding Asn creates the
oxyanion hole in subtilisins. Therefore, the mechanism of the tetrahedral intermediate
stabilization in sedolisins is more similar to that in aspartic peptidase 46 rather than that in
subtilisins. Replacement of the His and Asn in subtilisins by the Glu and Asp in
sedolisins, respectively, may be related to the acidic pH optimum of the sedolisin family.
(Table I-1) A possible explanation for the evolutions of sedolisins might be the demand
for some organisms of the serine peptidase activity under acidic environments. To study
the similarities and differences in the catalytic mechanisms of sedolisins, subtilisins and
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aspartic peptidases, details of the catalytic process by sedolisins are indispensable. Thus
computational simulations monitoring the proton transfers might be of great help.

Dynamic substrate-assisted catalysis (DSAC)
Substrate-assisted catalysis (SAC) is the process in which one or more functional
groups from the substrate, in addition to those from the enzyme, contribute to the rate
acceleration for the enzyme-catalyzed reaction. SAC has been observed in many cases of
both natural and engineered enzymes.

47-53

In the case of SAC in natural enzymes,

removal of a functional group of the substrate may inactivate the enzymatic catalysis. In
the case of SAC in engineered enzymes, addition on the subtrate with a functional group
that similar to mutated catalytic group of the enzyme may at least partially restore the
activity of the enzyme. 48 (Figure I-6 a, b) For example, in GTPase catalysis, it was found
that any mutation on the catalytic Gln resiude would inactivate the GTP hydrolysis.
However, a GTP analogue with an aromatic amine correctly at the mutated active site can
help to restore the catalytic activity of GTPase.48 (Figure I-6c) Another example is the
SAC in subtilisin catalysis, in which the P2-His or P1’-His can partially restore the
activity of H64A mutant. Thus the broadly specificity of wild type subtilisin is converted
into His specificity in the H64A mutant.

49

(Table I-2) Similarly, the product-assisted

catalysis has also been reported in the catalysis by human 8-oxoguanine DNA
glycosylase/β-lyase (hOGG1). The product of the glycosylase activity, 8-oxoguanine
(oxoG) was suggest to work as a general acid-base in the subsequent β-lyase catalytic
cascade of hOGG1. 54
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Many of previous studies on SAC only focused on the cases with well-positioned
substrate groups that can participate in SAC directly without significant conformational
changes. Here we introduce dynamic substrate-assisted catalysis (DSAC), in which
substrate groups require conformational changes triggered by bond breaking and making
events so as to contribute to the rate acceleration. As proposed in Figure I-7, the bond
breaking and making events, especially the protonation and deprotonation of Asp164 may
trigger the back and forth shifts of the P1 His side chain between the hydrogen bond with
the carbonyl of P2 Pro and the salt bridge with the carboxylate of Asp164, which may
help to lower the free energy barriers at different stages of the catalysis. It is reasonable
to assume that DSAC might have been overlooked in many enzyme catalyses, since its
dynamic feature may not be well reflected in static X-ray structures. Fortunately, this
dynamic feature can be well reflected in computational simulations, as demonstrated by
our QM/MM MD simulations on Kumamolisin-As.

Product specificity of histone methylation
It is believed that most eukaryotic DNA are wrapped around histone proteins in
nucleosome.55, 56 (Figure I-8) The N-terminal tails of the core histones are suggested to be
not only important in the stabilizations of the the DNA wrapping around the histone
octamer, but also indispensable in the formation of the higher order structure, 30-nm
fiber.55 The tails of the histone proteins are subject to a variety of post-translational
covalent modifications.57 (Figure I-9) These modifications form the so-called epigenetic
histone code58, 59 read by other proteins, which may lead to distinct downstream events in

Chapter I
the regulation of chromatin structure and gene expression.
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60

(Figure I-10) One such

modification is histone lysine methylation catalyzed by protein lysine methyltransferases
(PKMTs).61, 62 (Figure I-11) The publications related to “histone lysine methylation” in
recent years are summarized in Figure I-12. There have been several lysine residues on
histone proteins identified as the methylation sites, including H3-K4 (Lys4 of histone
H3), H3-K9, H3-K27, H3-K36, H3-K79 and H4-K20 (Lys20 of histone H4). The
preferences of PKMTs for the sites of methylation are called substrate specificity. The
methylated lysine residues can then serve as the docking sites for methyl-lysine binding
domains and effector proteins to mediate the downstream events in the regulation of
chromatin structure and gene expression.62 As far as we know, most of the PKMTs
contain the SET (Su(var)3-9, Enhancer-of-zeste, Trithorax) domain. The only exception
is Dot1p, whose structural scaffolding is totally different from the SET domain PKMTs.
A number of crystal structures of the complexes of the SET domain PKMTs (including
SET7/9, SET8, Clr4, DIM-5, vSET and pLSMT) have been determined,60 in which the
substrate lysine and the cofactor are on the opposite sides of the enzymes, with the target
lysine side chain accessing the active site and the cofactor through a narrow channel. The
crystal structures of the non-SET domain PKMTs (yeast Dot1p and human Dot1L) have
also been determined.63, 64
In addition to the substrate specificity, PKMTs may also differ in the ability to
transfer one, two or three methyl groups from S-adenosyl-L-methionine (AdoMet)
molecule(s) to the ε-amino group of the target lysine. This is because each of the three
protons on the ε-amino group of the target lysine may be replaced by a methyl group.
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This difference in degree of methylation is called product specificity of PKMTs, and
PKMTs can therefore be classified into mono-methylases, di-methylases and trimethylases. (Figure VII-1A) For example, the mono-methylase human SET7/9 generates
exclusively monomethyl H3 Lys4.65 Another SET domain PKMT, the tri-methylase
DIM-5 of N. crassa, generates primarily trimethyl H3 Lys9, which marks chromatin
regions for DNA methylation.66, 67 For the SET domain di-methylases and tri-methylases,
the methylation processes are believed to proceed processively without the release of the
intermediates from the active sites.67, 68 (Figure VII-1B)
Like the substrate specificity, the products that differ in the degree of lysine
methylation (mono-, di- or tri-methylation) may lead to distinct biological
consequences.60 Therefore, it is quite interesting to determine the origin of the product
specificity and to develop suitable computational models or techniques for the prediction
of the product specificity. Nevertheless, our understanding of product specificity is still
lacking.

Summary of Chapters
I performed the simulations reported in chapter III, IV, V, VI and VII, with some
extensive discussions with my advisor, Prof. Hong Guo and one of my lab members, Dr.
Haobo Guo. Three additional papers for which I am one of the co-authors are not
included in this thesis. A short summary of the chapters are listed as below.

Chapter I
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In chapter I, the first section is a general introduction for the concepts related to
our research, and the second section has a short summary of the contents for each
chapter.
In chapter II there is a general description of the computational and mathematical
methods used in our studies and analyses. The first section is an introduction of the
background about some quantum mechanical and the molecular mechanical approaches
developed for computer simulations, especially the SCC-DFTB/CHARMM22 method
that we used in our QM/MM MD simulations. The second section contains some
descriptions of the techniques we used to set up our simulations models, including the
link atom method and the stochastic boundary system as well as some basic parameters
(such as the integration steps and the simulations temperatures). The third section
provides a summary of the umbrella sampling method and the WHAM program, the
approaches for determination of the free energy change along a selected reaction
coordinate. In addition, this section describes the techniques we used for estimation of
statistical errors and energy correction based on comparison with higher level of QM
calculations on small models. For more detailed discussions of the methods used, please
check the Method section in the later chapters.
In chapter III, we discuss the QM/MM MD simulations on the CDA-ZEB-H2O
(cytidine deaminase-zebularine-3, 4-hydrate) complex. Understanding the origin of the
tight binding of the transition state analogue (TSA) at the active site may provide
important insights into the mechanism by which the enzyme stabilizes the transition state
of the reaction. In these simulations, the features of the X-ray structure were successfully
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reproduced. The simulation of the E104A mutant confirmed the critical function of
Glu104 in the stabilization of the tetrahedral intermediate.
In chapter IV, a complex similar to CDA-ZEB-H2O was investigated. The similar
result from yCD-DHP (yeast cytosine deaminase-hydroxyl-3, 4-dihydropyrimidine)
complex confirmed our consideration of the importance of the proton transfers between
TSA and the catalytic residue. Similar to our earlier result on CDA, 19 the transition state
analogue DHP is unstable at the active site of yCD and tends to exist in an alkoxide-like
structure instead of a hydroxyl form, with the proton of the hydroxyl transferred to the
carboxylate of the catalytic residue Glu64. When this proton transfer is prevented, the
tetrahedral intermediate with a hydroxyl was estimated to be 8-9 kcal/mol less stable.
In chapter V, the nucleophilic attack process in another enzyme, Kumamolisin-As,
was simulated. One of the aims is to study the possible role of proton transfer from
Asp164 to the substrate in the stabilization of the tetrahedral intermediate (TI). As
expected, the proton on Asp164 was transferred to the tetrahedral intermediate during the
late stage of the nucleophilic attack. Prevention of this proton transfer resulted in an
unstable tetrahedral intermediate complex. Correspondingly, the free energy simulations
indicate a much higher energy with no energetic minimum for the TI complex if the
proton is fixed on Asp164. There was a surprise finding that the side chain of His at P1
site of the substrate undergoes a significant conformational change. The original
hydrogen bond of this His with the carbonyl of Pro at P2 site is broken, and the side chain
undergoes a rotation to interact with the unprotonated carboxylate of Asp164. Therefore,
the side chain of P1 His seems to contribute to the stabilization of the tetrahedral
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intermediate. This substrate-assisted catalysis (SAC) may at least partially contribute to
the substrate specificity of Kumamolisin-As. Actually, replacement of this His to Phe
resulted in 5kcal/mol higher energetic barrier for the nucleophilic attack according to the
free energy simulations.
In chapter VI, the simulations on the catalytic mechanism of Kumamolisin-As
were extended to the whole process of acylation. The difference between the distances of
C-N and C…Oγ(Ser278) was used as the reaction coordinate, and both the nucleophilic
attack by Ser278 and the breaking of the scissile peptide bond could be described in the
same umbrella sampling simulations. The results of these simulations confirmed that
Asp164 acts as a general acid-base to protonate/deprotonate the tetrahedral intermediate,
which resulted in an energetic minimum during the acylation. With the proton fixed on
Asp164, a 10kcal/mol higher energetic barrier was estimated by free energy simulations,
and no energetic minimum was obtained near the area of the tetrahedral intermediate. The
results confirmed the earlier result on the important contribution of the Asp164 in
stabilization of the tetrahedral intermediate through a general acid-base mechanism. In
addition, comparison of the activation barriers for the transition states of nucleophilic
attack and the peptide bond breaking seems to suggest that the nucleophilic attack on the
substrate may not be the rate-limiting step of acylation. Accompanying the back and forth
proton transfers between the tetrahedral intermediate and Asp164, the positively charged
side chain of P1 His is shifted back and forth between the negatively charged carboxylate
of Asp164 and the carbonyl of P2 Pro. This dynamic feature of P1 His side chain allows it
to participate in the stabilization of complex at different stages of the acylation. To
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distinguish it from the conventional SAC, we define the effect of P1 His side chain as
dynamic substrate-assisted catalysis (DSAC).
In chapter VII, QM/MM MD simulations were applied to the 1st, 2nd and 3rd
methyl transfers from AdoMet to the target lysine/methyl lysine in the N. crassa DIM-5
(a trimethylase) and human SET7/9 as well as their mutants. The results suggest that
there are some correlations between the product specificity and the structures of the
reactant complexes, the relative difference in free energy barriers for methyl transfers, the
distributions for distance r(CM…Nζ) and angle θ (the distance for Nζ to attack the methyl
group and angle between the orientation of the electron lone pair on Nζ relative to the CMSδ bond). The relative difference in free energy barriers for methyl transfers can be
summarized into a triplet code, which can pretty well explain the product specificity
switch by F281Y mutation in DIM-5 and Y305F mutant in SET7/9.
In chapter VIII, a general conclusion of our QM/MM MD simulations on
enzymes is summarized, and some future directions of the simulations in next step are
suggested.
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Appendix
Table I-1. Comparison between the features of sedolisin and subtilisin
The members of sedolisin family and of subtilisin family share some similar features. Both of them have a
catalytic triad, which is Ser-Glu-Asp in sedolisin and Ser-His-Asp in subtilisin. In sedolisin, an Asp may
play an important role in the stabilization of the tetrahedral intermediate (TI), while the corresponding
residue is an Asn in subtilisin. In addition, these residues have a similar structural fold in sedolisin and in
subtilisin, suggesting a similar ping-pong mechanism in catalysis. On the other hand, the difference in the
conserved residues between sedolisin and subtilisin may lead to their different optimum pH conditions.
Sedolisin favors acidic condition, while subtilisin favors neutral or alkaline conditions.

Sedolisin

Subtilisin

Catalytic triad

Ser-Glu-Asp

Ser-His-Asp

TI stabilization

Asp

Asn

pH optimum

Acidic

Neutral or alkaline

Table I-2. Substrate-assisted catalysis in subtilisin
P2-His or P1’-His can partially restore the activity of H64A mutant. Thus the broadly specificity of wild
type subtilisin is converted into His specificity in the H64A mutant. (From Ref. 49)
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Figure I-1. Thermodynamic parameters of uncatalyzed and CDA-catalyzed cytidine
deamination
It is generally believed that the efficiency of enzymes mainly lies in their abilities to stabilize the transition
state and lower the activation barriers of the reactions. An example of CDA catalysis is shown here. The
energetic barrier of catalyzed reaction was determined to be 16.4kcal/mol lower than that of uncatalyzed
reaction at 25ºC. (From Ref. 32)
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2.94

His102

2.88

Glu104

2.49

2.88
Asn89
2.63

Glu91
Figure I-2. The X-ray structure of CDA-ZEB-H2O complex
The X-ray structure of CDA-ZEB-H2O complex has an abnormally longer C4-O4 bond as 1.6Å and an
unexpected low barrier hydrogen bond of 2.5Å between O4 and Oε1 of Glu104, (shown in red) even with a
restraint of 1.43 Å for C4-O4 bond and a restraint of 2.8Å for the O4…Oε1 distance during the refinement.
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Figure I-3. Gene-directed enzyme prodrug therapy (GDEPT)
A DNA containing an enzyme-encoding gene is delivered to the tumour using viral or non-viral vectors.
Only a fraction of the target cells will express the foreign gene and synthesize the enzyme. After systemic
injection of the prodrug, cytotoxic activation takes place only at the cells with the enzymes. The bystander
effect allows the activated drugs to diffuse into neighbouring untransfected cells and killed them. (
transfected cell; (
(

), untransfected cell; ( ), enzyme; (

), immune response. (From Ref. 37)

), activated drug; (

),

), dead cells;
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Figure I-4. Sequence alignment of sedolisins
The sequence alignment of some sedolisin members revealed four totally conserved residues, including the
possible catalytic triad S-E-D (in the fourth and the first section) and the D (in the second section) that may
contribute to the stabilization of tetrahedral intermediate, as marked in red. (From Ref. 45)
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Figure I-5. Proposed catalytic mechanism of kumamolisin-As
Similar to the ping-pong mechanism in classical serine peptidase, the whole reaction circle of can be
separated into two sections, acylation (left part) and deacylation (right). Each section has a different
substrate bound at the beginning and a different product released at the end. The product release in each
section is required to allow the binding of the substrate of the next section. During the acylation, the serine
residue is the catalytic nucleophile to attack the substate peptide bond, while the nearby Glu acts as the
general base to accept the proton from Ser at the time of the nucleophilic attack, and then act as the general
acid to protonate the nitrogen forming the leaving N-terminal group. During the deacylation, this Glu still
act as the general acid-base to accept a proton from the attacking water molecule and give it back to the
deprotonated Ser of the acyl-enzyme. At the same time, the Asp may act as a general acid to protonate the
oxygen of the tetrahedral intermediate (TI) and contribute to the TI statbilization.
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(c)

Figure I-6. Substrate-assisted catalysis
(a) SAC in natural enzyme: Removal of a functional group of the substrate may inactivate the enzymatic
catalysis. (b) SAC in engineered enzymes: Addition on the subtrate with a functional group that similar to
mutated catalytic group of the enzyme may at least partially restore the activity of the enzyme. (c) SAC in
GTPase catalysis: Any mutation on the catalytic Gln resiude would inactivate the GTP hydrolysis by
GTPase. However, a GTP analogue with an aromatic amine correctly positioned at the mutated active site
can help to restore the catalytic activity of GTPase. (From Ref. 48)
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Figure I-7. Proposed dynamic substrate-assisted catalysis (DSAC) in KumamolisinAs catalysis
The bond breaking and making events, especially the protonation and deprotonation of Asp164 may trigger
the back and forth shifts of the P1 His side chain between the hydrogen bond with the carbonyl of P2 Pro (B,
enzyme-substrate complex; D, E, acyl-enzyme; G, enzyme-product complex) and the salt bridge with the
carboxylate of Asp164 (C, tetrahedral intermediate 1; F, tetrahedral intermediate 2), which may help to
lower the free energy barrier for different step at different stage with different interactions.
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Figure I-8. Necleosome and histones
The nucleosome is the fundamental building block of eukaryotic chromatin, and histone proteins may play
an important role in packaging DNA into nucleosome and futher into higher order chromatin structures.
(Revised from Ref. 55, 56)
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Figure I-9. Sites of post-translational modifications on histones
The tails of the histone proteins are subject to a variety of post-translational covalent modifications. The
methylations on lysines are indicated as blue dots. (From Ref. 57)
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Figure I-10. Association of biological functions and histone modifications
The covalent post-translational modifications on histone tails may be associated with distinct biological
downstream events in the regulation of chromatin structure and gene expression. Only the modifications on
histone 3 and histone 4 are shown here. Under the list, the symbols of the biological functions are explained.
The abbreviation of the associated or correlated covalent modifications on histones are: Me, methylation;
Ac, acetylation; Ub1, monoubiquitination; Su, sumoylation; Cit, citrullination; Phos, phosphorylation.
(Revised from Ref. 60)

Chapter I

32

Figure I-11. Protein lysine methyltransferases (PKMTs) and methyl-lysine binding
proteins
(A) The protein lysine methyltransferases are grouped based on their target sites (H3-K4, H3-K9, H3-K27,
H3-K36, H3-K79 and H4-K20) and their source (yeast: red; worm: yellow; fly: pink; mammalian: purple).
(B) The methyl-lysine binding proteins bind the methylated lysines through their methyl-lysine binding
domains, such as the chromodomain (orange), the tudor domain (green) and the WD40-repeat (blue).
(Revised from Ref. 62; more PKMTs, methyl-lysine binding domains and methyl-lysine binding proteins
are summarized in Ref. 60)
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Figure I-12. Publications on the topic of “histone lysine methylation”
The numbers of publications on the topics related to the lysine methylation by PKMTs are quickly
increasing recent years. The numbers in blue are those published in Cell, Science and Nature; the numbers
in red are those published in other journals.
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Quantum Mechanical (QM)/Molecular Mechanical (MM) Molecular
Dynamics (MD) Simulations
The QM/MM hybrid potential combines the speediness of Molecular Mechanical
(MM) potentials and the generality of Quantum Mechanical (QM) potentials and can be
used to model enzymatic reactions involving bond breaking and making.
Currently, there are a number of force fields widely used for the Molecular
Mechanical (MM) descriptions, such as AMBER (Assisted Model Building and Energy
Refinement), CHARMM (Chemistry at HARvard Macromolecular Mechanics),
GROMOS (GROningen MOlecular Simulation), and OPLS (Optimized Potential for
Liquid Simulations).2-6 The common advantage of these empirical approaches is their
simplicity, which makes them applicable to the macroscopic systems like proteins, DNAs
and other biological molecules. In our simulations of the catalytic mechanisms, the allatom CHARMM22 force field7 was used for the enzyme and the modified TIP3P model8
implemented into the CHARMM program was used for the solvent water molecules. The
parameters of this CHARMM force field treat all atoms explicitly.7 In contrast, the older
versions, such as the extended-atom force field CHARMM19, only treats polar
hydrogens explicitly, while the nonpolar hydrogens were treated as part of extended
atoms of the alkyl groups. The parameters of CHARMM22 were gradually refined to a
force field that is well-balanced between the bonding and nonbonding interactions and
among the solvent-solvent, solvent-solute, and solute-solute interactions. In order to
simplify the calculation on the solvent molecules, the explicit water model TIP3P uses
three point charges to describe water molecules and ignores the internal interactions.8
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Solvent models can also include implicit solvent models, such as GBMV (Generalized
Born using Molecular Volume) module9, 10 of CHARMM, which looks as the solvents as
a continuous medium instead of individual solvent molecules.
Quantum Mechanical (QM) potentials are critical for the simulations with
permission of electron redistribution caused by the bond-breaking, bond-making, or other
processes. There have been many ab initio approaches developed, such as Hartree-Fock
(HF) theory, MP2 theory, and density functional theory (DFT) methods.2 A widely used
hybrid-functional version of DFT, B3LYP (Becke, three-parameter, Lee-Yang-Parr)11
that implemented in Gaussian program was used in our lab for calculations on small
model systems. However, the ab initio QM methods are generally very time-consuming.
Consequently, many semi-empirical methods have been applied to the quantum
mechanical calculations, such as MNDO (Modified Neglect of Diatomic Overlap), AM1
(Austin Model 1), PM3 (Parameterized Model 3), and SCC-DFTB (Self-Consistent
Charge Density Functional Tight Binding)

12, 13

. In these semi-empirical approaches, the

SCC-DFTB method is derived from density functional theory with a second-order
expansion of the DFT total energy in the variations of charge density variation relative to
a chosen reference.13 This semi-empirical density-functional method is as fast as AM1
and PM3, but gives more reliable results of energies and vibration frequencies in a
number of biological models, such as those of the triosephosphate isomerase (TIM)

14

.

The energies determined by SCC-DFTB are comparable to the high-level DFT methods,
such as B3LYP, for some systems with or without MM potentials. The application of
SCC-DFTB/CHARMM method has also been applied to the study of enzyme chorismate
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Therefore, in our simulations we had this

approach used in the quantum mechanical calculations, which generally include the
substrate/ligand and the side chains of catalytic residues.

Construction of Simulation Models and the conditions in simulations
The X-ray structures of the enzymes studied were obtained from the Protein Data
Bank.33 The hydrogen coordinates were also built onto the x-ray structures by CHARMM
program. In the construction of the model for kumamolisin-As-substrate complex, the
structure of pro-kumamolisin (PDB ID: 1T1E) was superimposed onto the structure of
kumamolisin-As-inhibitor complex (PDB ID: 1SIO) using the convenient program MOE1.
With a 5 amino acid peptide of the linker fragment isolated from 1T1E as the substrate,
and with the inhibitor deleted from 1SIO, the resulting system was revised and minimized
in gas phase by MOE, to be the substrate complex model.
In order to apply QM/MM methods in our simulations, the simulation models are
divided into QM part and MM part, for which SCC-DFTB and CHARMM force field are
used in the calculations, respectively. For the hybrid QM/MM method one key question
is how to deal with the interface between the QM part and the MM part, especially with
covalent bonds between the two parts. Actually, in many cases it is unavoidable to have
covalent bonds on QM/MM interface, such as the Cα-Cβ bonds of the catalytic residues.
To deal with such covalent bonds, several methods have been developed in earlier works,
such as link-atom methods, capping-atom methods and hybrid-orbital methods.

2, 17-19

Adapted Link-atom method is the most widely used method for semi-empirical QM
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functions. Although often criticized for addition of extra, unphysical atoms, this approach
has the advantages of simplicity and convenience. In this method, generally imaginary
hydrogen atoms are placed at about 1Å from the QM atom along the covalent bonds on
the boundary. These link atoms are included in the QM part, acting as the MM atom on
the other end of the covalent bond, so as to satisfy the valency of the QM atom in the QM
calculations. On the other hand, these dummy atoms have no interactions with the MM
atoms calculated.34
For example, in the CDA-ZEB-H2O complex, it was believed that the interactions
between TSA and Glu104 are only electrostatic interactions or low barrier hydrogen
bond.20 Thus in our first model, only the transition state analogue was included in the QM
region, which only permits nonbonding interactions between the QM part and the MM
part. The QM/MM MD simulations reproduced the structure consistent to the X-ray
structure, including the abnormal longer C4-O4 bond as 1.6Å and the relatively shorter
low barrier hydrogen bond between O4…Oε1(Glu104) as 2.5Å. However, in this model
the proton transfers between the TSA and the catalytic residue Glu104 are prohibited.
Therefore, the QM part was expanded to the side chains of the catalytic residue using the
link atom approach. The computational simulations on this new model resulted in much
more stable structures before and after the nucleophilic attack. In the structure of the
tetrahedral intermediate after the nucleophilic attack, a normal length of C4-O4 bond less
than 1.5Å was observed; the proton of zinc-hydroxide was totally transferred to the
carboxylate of Glu104, forming a normal hydrogen bond with O4…Oε1(Glu104) distance
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as 2.7Å. This more reasonable structure was estimated to be 8kcal/mol more stable than
the model without permission for the proton transfers.21
Stochastic Boundary (SB) system22 was used in our simulations of the catalytic
mechanisms of enzymes, in order to further reduce the size of our simulations models. A
typical SB system is shown in Figure II-1. Normally an atom close to the active center is
selected as the reference point, which may also be the center of mass of the whole model
or selected groups. The deleted part is called as the reservoir region, while the part left is
called as the reaction zone. The reaction zone is further divided into the reaction region
and the buffer region around it. The atoms in the buffer region were propagated by
Langevin dynamics, in which the friction constants for the protein atoms can be
calculated (e.g., 250ps-1 and for the water molecules as 62ps-1). The atoms in the reaction
region were propagated by molecular dynamics, and generally separated into QM part
and MM part as described above.
Energy minimizations and dynamic equilibrations were then performed on the
constructed simulation models. With QM part fixed, the constructed models are generally
first minimized by 500 steps of steepest descent (SD) method23, which can improve a
very poor structure very fast but is relatively inefficient in convergency. The better
structure is further minimized by 5000 to 10000 steps of conjugate gradient technique
(CONJ)

24

or adapted basis Newton Raphson (ABNR)

4

method to search for a stable

minimum. Following minimizations, the structure is simulated by dynamic equilibrations.
In these simulations, the temperature of the system is gradually increased from 50K to
300K (or the most reactive temperature of the enzyme) and kept equilibrated at that
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temperature for several hundred picoseconds to several nanoseconds. During the
simulations, the SHAKE algorithm25 is applied as constraint for the covalent bonds
involving hydrogen atoms, so as to allow 1fs time step to be used for integration of the
equations of motion.

Free Energy Change Determination
In order to determine the free energy change along a certain reaction coordinate
(Potential of Mean Force), we used Umbrella Sampling methods26, 27 and the weighted
histogram analysis method (WHAM) program28-30, which have been implemented into
CHARMM.
The configurations far from the equilibrium, such as those around the transition
states, are hard to be sampled in a normal simulation. The umbrella sampling methods
can force the system to explore these regions of coordinate space by using a harmonic
potential function. This harmonic function has been defined as

U=

1
× K × (r − r0 ) E
E

(1)

in the CHARMM package, where E is default to be 2, K is the force constant, r is the
reaction coordinate selected for PMF, and r0 is the origin of the harmonic function on the
selected reaction coordinate. The selected reaction coordinate may be a critical structural
parameter that changes in the chemical transformation (like distance, bond angle, or
dihedral angle), as well as the combination of different variables, such as the difference
between two distances r = r(C-N) – r(C…Oγ) in our simulations of the acylation of
kumamolisin-AS. This harmonic function can force the system to explore specific regions
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of the reaction coordinate, r0, especially the transition state of the energetic barrier that is
hard to be sampled without a bias in potential. With a series of r0, generally in about 20
simulation windows in our researches, the system can be forced to explore the
configurations along the selected reaction coordinate.
Based on the data of umbrella sampling, the WHAM program statistically
translates the probability distributions of the configurations within a series of bins along
the selected reaction coordinate into the relative free energy change as the function of this
reaction coordinate.28-31 Because the overlapping probability distributions between
different simulation windows are critical to WHAM in the evaluation of the relative free
energy change between different regions of the reaction coordinate, it is important to
select probable force constants and the origins of the harmonic functions for each
simulation window, so that the probability distributions can have enough data in the
overlapping regions.
The 95% confidence interval in the free energy determined by WHAM was
calculated based on the difference between the upper and lower limits.32 According to
this approach, the statistical error of the PMF is mainly related to the distribution
probability in each bin. That is, the bins with higher distribution density have lower
statistical errors. Generally the configurations around the transition state of the free
energy barrier are hard to be sampled and results in lower quantity of snapshot frames in
each bins, which makes the confidence intervals of the statistical error at this region tend
to be larger. Therefore, more simulation windows or smaller intervals in r0 around the
transition state were adopted so as to lower the statistical error.
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In addition to the statistical error in PMF determination, a systematic error might
be possible from the semi-empirical SCC-DFTB method. It was suggested to compare the
result of SCC-DFTB method with higher level ab initio or DFT approach on a model
system in new applications so as to correct the energy.14 The energy correction for our
simulations were mainly based on comparison between the single point energies
determined by SCC-DFTB and by B3LYP/6-31G(d,p) on simplified model systems,
which were generally a part of or same as the QM region in the SCC-DFTB/CHARMM
simulations. The single point configurations along the reaction coordinate were generated
through a series of constrained iterative minimizations on the model system in gas phase
using SCC-DFTB. When r0 was changed stepwise from the reactant state to the product
state, or reverse, a series of snapshot configurations could be sampled along the reaction
coordinate. Then the single point potential energies of the generated structures were
determined by SCC-DFTB and B3LYP/6-31G(d,p) separately, and the potential energy
surfaces (PESs) along the reaction coordinate were compared. If possible, the SCCDFTB energies were fit to the PES by B3LYP/6-31G(d,p) with certain corrections, which
were then applied to the relative free energies obtained from the QM(SCC-DFTB)/MM
umbrella sampling simulations.
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Appendix

Figure II-1. Stochastic boundary system
A sample of stochastic boundary system for CDA-ZEB-H2O model is shown. Using the N1 atom of ZEBH2O as the reference center, the out most reservoir region is more than 18 Ǻ away from the reactive site. It
has quite less effect on the reaction so it is deleted. The region left is called reaction zone, which is further
separated into the reaction region within 16Ǻ and the buffer region between 16Ǻ and 18Ǻ. The atoms in the
buffer region were restrained by Langevin dynamics. The atoms in the reaction region are divided into
quantum mechanical part and molecular mechanical part, and treated by SCC-DFTB and CHARMM force
field, respectively.
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Quantum Mechanical/Molecular Mechanical
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Deaminase: from Stabilization of Transition-State
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Abstract
Cytidine deaminase catalyzes the hydrolytic deamination of cytidine to uridine
and accelerates the rate of the reaction by 1011-fold. The enzyme is strongly inhibited by
the transition-state analog inhibitor zebularine 3, 4-hydrate, and a fraction of transition
state stabilization is captured by the interaction of this inhibitor at the active site.
QM/MM molecular dynamics and free energy simulations are performed for E. coli
cytidine deaminase (CDA) complexed with zebularine 3, 4-hydrate to understand the
origin of the structural stability of zebularine 3, 4-hydrate in the active site and elucidate
the mechanism of the CDA-catalyzed reaction. It is shown that the existence of Glu-104
is essential for the structural stability and integrity of zebularine 3, 4-hydrate. The
simulations also reveal that the covalent bond between C4 and the 4-OH group in ZEBH2O undergoes transient bond-breaking and making on a picosecond scale in the active
site, resembling the process of the nucleophilic attack by the zinc hydroxide group on C4
during the catalysis. The role of the active-site interactions in stabilizing zebularine 3, 4hydrate and transition state is discussed. The results demonstrate that understanding the
stability and integrity of TSAs in the active sites may provide important insights into the
origin of transition state stabilization.
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Abbreviation:
CDA, cytidine deaminase; ZEB, zebularine, (Pyrimidin-2-one ribonucleotide);
ZEB-H2O, zebularine 3, 4-hydrate; TSA, transition state analog; TS, transition state;
QM/MM, quantum mechanical/molecular mechanical; MD, molecular dynamics; SCCDFTB, self-consistent charge density functional tight-binding.
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Introduction
Enzymes are the most proficient catalysts. Their catalytic power lies in the
enzyme's ability to stabilize transition state (TS) and to lower the energy barriers for
enzyme-catalyzed reactions, although other factors may be involved as well.
Understanding the forces responsible for transition state stabilization is of fundamental
importance for a microscopic description of the catalytic mechanism, but also for the
design of effective enzyme inhibitors or improvement of existing enzymes (or abzymes)
for catalyzing chemical reactions. It has been recognized1-3 that a molecule that mimics
the altered structure of substrate in the transition state should bind to the enzyme tightly,
and such a transition state analog (TSA) may capture a significant fraction of transition
state stabilization. The enzyme-TSA complexes, where the inhibitors are designed based
on possible catalytic mechanisms, can therefore be used as models for understanding the
properties and structural features of transition states (which have a very short lifetime and
are difficult to study). A number of the TSA inhibitors have been identified.4-8 It has been
shown that some of them can indeed bind to enzymes significantly stronger than the
corresponding substrates, as originally hypothesized.1 The precise arrangements of many
TSA inhibitors in the enzyme active sites have also been determined by X-ray
crystallography9-10 which led to significant insights into the structural origins of enzyme
catalysis as well as the possible roles of active-site interactions in transition state
stabilization.
The ability of well-designed TSAs to mimic the transition state or intermediate
structures and to capture a significant fraction of transition state affinity implies that the
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structural stability and integrity of TSAs in the active sites may depend, at least in some
of the cases, on the same forces that are responsible for transition state stabilization
during the enzyme-catalyzed reactions. Removal of certain key residues crucial for the
stability and integrity of the TSA inhibitors could also affect the transition state
stabilization and lead to a reduced catalytic efficiency. Thus, determination of the
conditions for existence of stable TSAs in the enzyme active sites should be of
considerable interest, as the problem of understanding the origin of transition state
stabilization might be simplified to a stability problem concerning TSAs in the enzymes’
active sites. The large number of high resolution structures of enzyme-TSA complexes9-10
can be used directly as the initial coordinates in computational studies; they may also
serve as an important testing ground for theoretical predictions. Although all the
questions concerning transition state stabilization and catalytic mechanisms are unlikely
to be solved based on our understanding of the stability of TSAs in the active sites alone,
important insights may be obtained from such studies.
Here Quantum mechanical/molecular mechanical (QM/MM) molecular dynamics
simulations are performed for E. coli cytidine deaminase (CDA)11 complexed with the
transition state analog zebularine 3,4-hydrate (ZEB-H2O) (Figure III-1B) to elucidate the
origin of the stabilization of zebularine 3,4-hydrate by the active-site interactions. One
advantage of the QM/MM treatments of the enzyme complex is that they allow the QM
part of the system (e.g., ZEB-H2O and zinc in this study) to undergo chemical
transformations during molecular dynamics (MD) simulations in the search for stable
chemical structure(s) under a given environment. The free energy approach can be used
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to determine the free energy changes associated with chemical and conformational
transformations. However, it is extremely time consuming to perform free energy
calculations with ab intio methods, and semi-empirical approaches need to be used. There
are different semi-empirical methods available. In this paper, we use a semi-empirical
density functional method, SCC-DFTB,25a to describe the QM part, because this approach
has been extensively tested against high level quantum mechanical methods for a range
of active site models containing zinc.25b It was found that the SCC-DFTB approach
reproduced structural and energetic properties rather reliably for the active sites of these
enzymes.25b The SCC-DFTB/MM approach has been tested previously for chorismate
and used to study the enzyme chorismate mutase.28-29
CDA catalyzes the hydrolytic deamination of cytidine to uridine (Figure III-1A)
and has been a subject of extensive investigations.11-24 It is one of the efficient enzymes
known with a rate acceleration of 1011-fold.22 It has been shown that the deamination
proceeds stepwise through a tetrahedral intermediate (formed by the nucleophilic attack
by the zinc hydroxide group on C4) with ammonia elimination as the major ratedetermining step.24 The catalysis depends critically on the presence of Glu104, and the
mutation of Glu104 to Ala reduces kcat by 108-fold.14 The side chain of Glu104 seems to
play multiple roles and is thought to provide all the necessary proton transfer functions
during the catalysis (i.e., generating the zinc hydroxide nucleophile, protonating the
pyramidine ring nitrogen and shuttling the proton from the 4-OH group to leaving amino
group).12 Glu104 is believed to be important for transition state stabilization, probably
through the formation of a strong hydrogen bond with the 4-OH group of the tetrahedral
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intermediate.11 The observation that the mutation of Glu104 to Ala increases the
enzyme's affinities toward substrate cytidine and product uridine by factors of 30 and
120, respectively, has led to the suggestion that Glu104 may be involved in the ground
state destabilization as well.13
Zebularine (ZEB. See Figure III-1B) and 5-fluorozebularine (FZEB) bind CDA in
hydrated forms (ZEB-H2O and FZEB-H2O, respectively),11-12 and the hydration processes
seem to be catalyzed by CDA by a mechanism similar to the formation of the tetrahedral
intermediate during the CDA-catalyzed reaction.10 Interestingly, the

19

F-NMR

resonance13 of 5-[19F]FZEB showed that whereas the inhibitor is bound by wild-type
enzyme as the 3, 4-hydrated species, it is bound by the E104A mutant without
modification in a form that resembles the substrate in the ground state. The detailed
structural origin for the different behavior is still not clear. CDA is strongly inhibited by
ZEB-H2O and FZEB-H2O; e.g., the enzyme's affinity (Ki = 1.2 x 10-12M) for ZEB- H2O
exceeds the affinity for the product uridine and the inhibitor 3, 4-dihydrozebularine
(DHZ) (for which the 4-OH group of ZEB-H2O is replaced by a hydrogen atom) by a
factor of approximately 108.23 Thus, the enzyme appears to have a very strong ability to
stabilize the rare 3, 4-hydrated species in the active site that resemble the tetrahedral
intermediate formed by the nucleophilic attack by the zinc hydroxide group on C4.12 In
this chapter, the stability of ZEB-H2O is studied, and it is shown that the presence of
Glu104 is essential for the existence of zebularine 3, 4-hydrate in the CDA active site.
The QM/MM molecular dynamics simulations demonstrate that whereas the covalent
bond between C4 and the 4-OH group in ZEB-H2O exists in wild-type CDA, it is broken
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in the E104A mutant followed by a proton transfer from the 3-NH group to the
hydroxide. The simulations also show that, unlike conventional covalent bonds, the bond
between C4 and the 4-OH group in the wild-type CDA-ZEB-H2O complex undergoes
large fluctuations and breaks transiently during the simulations. The QM/MM MD
simulations of the CDA-ZEB-H2O complex seem to be able, not only to capture the
structural features of the CDA-ZEB-H2O complex, but also to provide some important
insights into the dynamic events associated with the nucleophilic attack by the zinc
hydroxide group on C4 during the catalysis.

Methods
A fast semi-empirical density-functional approach (SCC-DFTB),25 recently
implemented in the CHARMM program,27 was used for QM/MM molecular-dynamics
simulations.26 The SCC-DFTB approach has been extensively tested against high level
quantum mechanical methods for a range of active site models containing zinc.25b It was
found that the SCC-DFTB approach reproduced structural and energetic properties rather
reliably.25b The QM(SCC-DFTB)/MM molecular-dynamics simulations have been used
recently to study the conformational transitions of substrate in chorismate mutase.28-29
The initial coordinates for the simulations were obtained from the crystal structures of the
CDA-TSA complex (1CTU),11 which have the transition state analog ZEB-H2O at the
active site. It has been suggested19 that there might be a trapped water molecule in the
CDA-ZEB-H2O complex occupying the site of the leaving group (-NH2 group) of the
altered substrate in the transition state. Therefore, a water molecule was manually docked
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into this site. The MD simulations were performed on the CDA-ZEB-H2O complexes
with and without this additional water, and the results are rather similar. ZEB-H2O and
zinc were treated by QM and the rest of the system by MM. To study the effects of the
interactions involving Glu104 on the stability and integrity of ZEB-H2O, Glu104 was
simply replaced by Ala based on the X-ray structure of the CDA-ZEB-H2O complex; the
structure for the E104A mutant is not available. The all-hydrogen potential function
(PARAM22)30 was used for MM atoms. A modified TIP3P water model31-32 was
employed for the solvent. The stochastic boundary molecular-dynamics method33 was
used for the QM/MM MD simulations. The system was separated into a reaction zone
and a reservoir region, which was deleted; the reaction zone was further divided into the
reaction region and the buffer region. The reference point for partitioning the system was
chosen as the N1 atom of ZEB-H2O (Figure III-1B). The reaction region was a sphere
with radius 16 Å, and the buffer region has R equal to 16 Å ≤ R ≤ 18 Å. Inside the
reaction region, the atoms were propagated by molecular dynamics, whereas atoms in the
buffer region were propagated by Langevin dynamics. The friction constants for the
Langevin dynamics were 250ps-1 for the protein atoms and 62ps-1 for the water
molecules. A 1fs time step was used for integration of the equations of motion, and the
results of the simulations were saved on every 50fs. In initiating the runs, 500 steps of
minimization using the steepest descent method were performed for the protein and
solvent atoms. Then 4,000 steps of minimization were performed for the entire stochastic
boundary system with the Adapted Basis Newton Raphson methods. The temperature of
the system was gradually increased from 50K to 300K (30ps) and equilibrated at 300K
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(40ps). The simulations were performed on the resulting systems involving ZEB-H2O for
several hundred picoseconds to 1ns. The umbrella sampling method34 implemented in the
CHARMM program along with the Weighted Histogram Analysis Method (WHAM)

35

was applied to determine the change of the free energy (potential of mean force) as a
function of the distance (from 1.45Å to 3.1Å) between C4 and O4 in ZEB-H2O; harmonic
umbrella potentials with a force constant of 100kcal/mol-Å2 were used. Twelve windows
were used to go from 1.45Å to 3.10Å. The trajectories obtained from the umbrella
sampling were used to study how the active site interactions change as functions of the
C4-O4 distance. That is, for each window in the umbrella sampling, the average distances
for the Oε2...H3, Oε1...H (O4) and Zn...O4 interactions as well as for the C4-O4 bond were
obtained from the corresponding trajectory. The average distances from different
trajectories were then plotted as functions of the C4-O4 distance. The umbrella sampling
method was also used to determine the relative stability of the structures before and after
the dehydration of ZEB-H2O in E104A; the difference between r1 (O4...H3) and r2 (N3-H3)
was used as the reaction coordinate with a force constant of 100kcal•mol-1 •radian-2.

Results
ZEB-H2O in wild-type CDA
An important test for the methods of the QM/MM MD simulations is to see if the
structures generated from the simulations agree with the structure determined by X-ray
crystallography. In Figure III-2A, an average active-site structure based on 2,000 frames
in the trajectory is compared with that of the X-ray structure.11 As can be seen from
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Figure III-2A, the active site structure of the CDA-ZEB-H2O complex from the QM/MM
simulations is rather close to the X-ray structure,

11

suggesting the computational

approaches used in this study are meaningful. In particular, the 4-OH group of ZEB-H2O
is coordinated to the zinc ion and hydrogen bonded to Oε1 of Glu104. The C4-O4 bond has
an average distance of about 1.6Å. Oε2 of Glu104 receives a hydrogen bond from the 3NH group. The additional ligands to zinc include Cys129, Cys132 and His102. The
distances for some of the interactions between the QM (e.g., zinc) and MM atoms (e.g.,
the atoms from Cys129, Cys132 and His102) seem to be slightly longer than those in the
X-ray structure, but the differences are rather small.
The fluctuation of the C4-O4 distance of ZEB-H2O as a function of time is plotted
in Figure III-2B; the fluctuation of the C3’-O3’ distance is also given for comparison.
Figure III-2B shows that the C4-O4 bond is essentially intact with an average distance of
~1.57 Å. This average distance is somewhat longer than the distance for a normal C-O
bond (e.g., for the C3’-O3’ bond of ZEB-H2O, the average distance is about 1.45 Å). A
relatively long C4-O4 distance (1.6 Å) was also obtained in the X-ray structure refinement
of the CDA-ZEB-H2O complex, 11 even though a restraint of 1.43Å was imposed for this
bond. The result of the QM/MM MD simulations is therefore consistent with the
experimental assignment. It is interesting to note that the distance fluctuations for the C4O4 bond are rather large. A striking observation from Figure III-2B is that the C4-O4 bond
undergoes transient bond breaking and making on a picoseconds scale during the
simulations; the bond distance approaches or exceeds 2.0Å about 2-3% of the times.
Figure III-2C shows the free energy (potential of mean force) as a function of the C4-O4
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distance. Consistent with the earlier observation, there is a second minimum near r(C4O4) = 2.1Å, corresponding to the transient structures with the relatively long C4-O4
distances. The existence of two minima indicates that there is equilibrium between two
different types of the structures for ZEB-H2O in the active site.
The changes of the Oε2 (Glu104)...H3 and Oε1 (Glu104)...H(O4) hydrogen bond
distances as functions of time are shown in Figure III-2D. The role of these two hydrogen
bonds has been a subject of previous discussions. It was proposed11-14 that the interactions
involving Glu104 play an important role in the transition state stabilization, probably,
through the formation of a strong hydrogen bond between the carboxylate and 4-OH
groups. As can be seen from Figure III-2D, the two hydrogen bonds involving Glu104 are
rather stable during the simulations. The average distance for the Oε1...H(O4) hydrogen
bond (1.6Å) is shorter than that for the Oε2...H3(N3) hydrogen bond (1.75Å), consistent
with the X-ray structure.11 It would be of interest to study how the interactions between
ZEB-H2O and CDA change as the C4-O4 distance decreases, in a process that mimics the
nucleophilic attack by the zinc hydroxide group on C4 during the CDA-catalyzed
reaction. In Figure III-2E, the average distances for the Oε2...H3, Oε1...H(O4) and Zn...O4
interactions obtained from the trajectories in the umbrella sampling (See Methods and
Figure III-2C above) are given as functions of the C4-O4 distance. As is evident from
Figure III-2E, the Oε1...H(O4) interaction is very sensitive to the C4-O4 distance. When
the C4-O4 bond is broken (e.g., with a distance greater than 2.1Å), the Oε1...H(O4)
interaction is rather weak with an average distance > 2.2 Å; the 4-OH group is on the top
of the carboxylate plane and does not have the angles for favorable hydrogen bonding
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interactions with Glu104 (not shown). When the C4-O4 bond is formed (i.e., with a
distance of 1.5-1.7Å), Oε1 of Glu104 and 4-OH form a strong hydrogen bond with an
average hydrogen bond distance of l.5-1.7Å. The Oε2...H3 hydrogen bond also strengthens
with the formation of the C4-O4 bond, but the change is much smaller. It is interesting to
note from Figure III-2E that the distance between O4 and Zn increases (from 1.81Å to
1.95Å) with decreasing the C4-O4 distance (from 2.3Å to 1.5Å). The average distance of
1.95Å between O4 and Zn is the same as that of the X-ray structure11 for the CDA-ZEBH2O complex, whereas the distance of 1.81Å is similar to the distance (1.80Å) in the
CDA-DHZ complex.11 The distances for the interactions of Zn with Cys129, Cys132 and
His102 were also examined. It was found that these distances increase by about 0.05Å
with the decrease of the C4-O4 distance. These changes are smaller than that for the ZnO4 distance (0.15Å), and quantum mechanical description of the enzyme side chains may
be necessary to obtain more reliable results.11
It is believed that the pyramidine ring nitrogen at position 3 accepts a proton from
Glu104 during the hydration of ZEB and the CDA-catalyzed reaction.12 In order to see
the effect of this protonation on the nucleophilic attack by the zinc hydroxide, the
simulations were performed on the complex where the proton was placed on Oε2 rather
than 3-N. It was found that the C4-O4 bond was broken during the energy minimization,
leading to ZEB and the zinc hydroxide group. The zinc hydroxide group was unable to
approach C4 with a distance of less than 2Å during the MD simulations (data not shown);
the average C4-O4 distance is 2.2Å. Therefore, the results of the simulations suggest that
the protonation of 3-N would make the nucleophilic attack much easier.
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ZEB-H2O in E104A
To obtain additional information concerning the role of Glu104 in stabilizing
ZEB-H2O, Glu104 was replaced by Ala. Figure III-3A plots the active site structures
representing three different stages observed during the MD simulations; only the
interactions involving the pyramidine ring are shown. The structure on the left represents
the early stage of the simulations. As can be seen from this structure, the C4-O4 bond is
broken and the 4-OH group exists as a zinc hydroxide ion. The figure in the middle
shows the active structure observed in the next stage of the simulations. The zinc
activated hydroxide oxygen has moved significantly and is now in the position to interact
with the 3-NH group. The figure on the right shows the active site structure in the final
stage; this structure was found to be stable during the rest of the simulations. As can be
seen from this figure, the hydroxide ion has already picked up the proton from N3 and
moved back to the initial position (i.e., on the top of C4), leading to the dehydration of
ZEB-H2O into zebularine and a water molecule. The umbrella sampling method was used
to determine the free energy change associated with the process given in Figure III-3A. It
was found that the free energy decreases by about 20kcal/mol as the proton transfers from
3-N to the hydroxide ion. Thus, the results of the simulations suggest that the hydroxide
ion is unstable without the presence of Glu104. In Figure III-3B, the O4-H3, N3-H3 and
C4-O4 distances are used to monitor the process shown in Figure III-3A. As can be seen
from Figure III-3B, the O4-H3 distance (red line) first changes from a distance of 3Å to
1.5Å so that O4 can interact with 3-NH. It then changes to 1Å, indicating that the
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covalent bond is formed between O4 and H3. At the same time the N3-H3 bond (blue line)
is broken.
Fig. 3C shows the free energy (potential of mean force) as a function of the C4-O4
distance in the E104A mutant (i.e., before the proton transfer discussed earlier); the free
energy curve was obtained in the same way as the one given in Figure III-2C except that
Glu104 was replaced by Ala. Consistent with the earlier observation, the C4-O4 bond
becomes unstable and cannot be formed in the mutant. It is interesting to note from
Figure III-3C that the mutation of Glu104 to Ala shifted the minimum on the free energy
curve to the other location at r(C4-O4) ~ 2.1Å identified earlier in the wild type enzyme.

Discussions
One of the key events in the CDA-catalyzed reaction is the nucleophilic attack by
the zinc hydroxide group on C4, leading to the formation of the hypothetical tetrahedral
intermediate (Figure III-1A). Thus, an important question is how CDA would be able to
stabilize this intermediate state and to lower the energy barrier for the reaction. The
ability of zebularine 3, 4-hydrate (ZEB-H2O) to mimic the intermediate structure and to
capture a fraction of the affinity for the transition state implies that the forces responsible
for the structural stability and integrity of ZEB-H2O in the active site may also be
responsible for the transition state stabilization. Thus, understanding how the enzyme is
able to stabilize this rare 3, 4-hydrated species in the active site may provide important
insights into the mechanism of the CDA-catalyzed reaction. The results of the QM/MM
MD simulations reported here demonstrate that ZEB- H2O is generally stable in the
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active site of the wild-type enzyme with an average structure close to the one observed
experimentally (Figure III-2A). However, its C4-O4 bond undergoes transient bondbreaking and making (Figure III-2B); the bond-making process resembles the
nucleophilic attack by the hydroxide group on C4 of ZEB in the hydration process. Thus,
the dynamic behavior of the C4-O4 bond seems to be quite different from conventional
covalent bonds (compare, for example, the fluctuations of the C4-O4 and C3’O3’ bonds in
Figure III-2B). It would be of interest to confirm this prediction experimentally and
examine if this interesting dynamic behavior exists in other enzyme-TSA complexes. The
observation from the X-ray crystallography11 that this bond is unusually long in the TSA
complex is consistent with the simulation results (See above). However, it does not
provide a direct support for the dynamic behavior. The umbrella sampling simulations
showed that there is equilibrium between two different types of the structures in the
active site with different C4-O4 distances (Figure III-2C). These two types of the
structures correspond to the stages before and after the nucleophilic attack, respectively.
Because the hydration of ZEB seems to be catalyzed by CDA by a mechanism similar to
the formation of the tetrahedral intermediate, the process of the nucleophilic attack by the
hydroxide group on C4 during the catalysis may have the similar dynamic behavior.
The question is how the active site interactions are able to shift the equilibrium
and lead to the formation of zebularine 3, 4-hydrate and, presumably, the tetrahedral
intermediate as well during the catalysis. Examination of the interactions as functions of
the C4-O4 distance revealed that the interaction that undergoes the most significant
change during the formation of the C4-O4 bond is the hydrogen bond between
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Oε1(Glu104) and H(O4) (See Figure III-2E). In particular, Oε1 and the 4-OH group can
form a strong hydrogen bond only when the C4-O4 distance is short (l.5-1.7Å). The
corresponding differential hydrogen bonding energy should be able to make an important
contribution to the stability of ZEB-H2O in the active site and, presumably, to transition
state stabilization as well. The role of the Oε1(Glu104)...H(O4) hydrogen bond in
transition state stabilization has been a subject of previous discussions. It was shown that
the hydrogen bond distance for this interaction in the CDA-ZEB complex is 0.2Å shorter
than the corresponding distance in the CDA-DHZ complex (i.e., between Oε1 and a
trapped water). This observation has led to the suggestion that the strength of this
hydrogen bond may increase with the development of the C4-O4 covalent character and
the energetic effect would be used for the transition state stabilization. The results of this
study support this previous suggestion and provide direct computational evidences that
the nucleophilic attack by the zinc hydroxide group on C4 leads to the strengthening of
the Oε1(Glu104)...H(O4) hydrogen bond.
It was suggested that one of the reasons for the increase of the strength of the
Oε1(Glu104)...H(O4) hydrogen bond is that the formation of the C4-O4 bond converts the
zinc-bound oxygen into a species more closely resembling an alkoxide group than a
hydroxyl group. As a result, the pKa of the 4-OH proton would be depressed toward to
that of the carboxylate, leading to a stronger interaction between these two groups. Other
factors may be involved as well. For instance, the formation of the C4-O4 bond leads to
smaller fluctuations for the OH group, making its interaction with Oε1 more stable.
Moreover, the 3-NH and 4-OH groups of ZEB-H2O (i.e., with an unbroken C4-O4 bond)
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seem to be in ideal relative positions to match OE1 and OE2 of the carboxylate group
from Glu104 (See Figure III-2A). The simultaneous formations of these two strong
hydrogen bonds may help to hold the two fragments of ZEB-H2O together and prevent
the C4-O4 bond from being broken.
The results discussed above indicate that the interactions involving Glu104 are
essential for stabilizing ZEB-H2O in the active site of the wild-type enzyme. The
QM/MM MD simulations on the E104A-ZEB-H2O complex provide additional insights
concerning the role of Glu104. It was shown that when Glu104 was replaced by Ala, the
covalent bond between C4 and the 4-OH group in ZEB-H2O was broken followed by a
proton transfer from the 3-NH group to the hydroxide, leading to the dehydration of
ZEB-H2O into ZEB and a water molecule (Figure III-3A, B). Thus, ZEB-H2O is likely to
be rather unstable in the E104A mutant. It has been observed from 19F-NMR resonance13
that whereas the wild-type enzyme binds FZEB (whose structure is very close to that of
ZEB) as the 3, 4-hydrated species (FZEB-H2O), the E104A mutant binds the inhibitor
without modification in a form that resembles the substrate in the ground state. Our
results are therefore consistent with the experimental observations. Moreover, the
simulations suggest that the active site water may not be in split form in E104A. This is
in contrast with the case for the wild type enzyme where the water is believed to be in
split form with the hydroxide ion on zinc and proton on Glu104.19-20 The different
binding modes might contribute to the loss of the activity as a result of the mutation;

14

they could also be related to the different affinities of the wild-type enzyme and E104A
mutant toward substrate cytidine.13
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The results of the simulations demonstrated that understanding the stability and
integrity of well-designed tight binding TSAs in the enzymes active sites may provide
important insights into the origin of transition state stabilization during the catalysis.
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Figure III-1. Reaction catalyzed by CDA and TSA of this reaction
(A) The hydrolytic deamination of cytidine to uridine catalyzed cytidine deaminase via a tetrahedral
intermediate. (B) Pyrimidin-2-one ribonucleoside (zebularine or ZEB) and zebularine 3, 4-hydrate (ZEBH2O). ZEB-H2O resembles the tetrahedral intermediate in (A) and the hydration process seems to be
catalyzed by CDA by a mechanism similar to the formation of the tetrahedral intermediate during the
CDA-catalyzed reaction.
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Figure III-2. Simulation results of CDA-ZEB-H2O complex
(A) Left: An average active-site structure obtained from 2,000 frames (or 100ps) of the molecular
dynamics simulations of the CDA-ZEB-H2O complex. The further increase of the number of frames has
little effect on the structure. Distances are in Å. The 4-OH group of ZEB-H2O is coordinated to the zinc ion
(2.0Å) and hydrogen bonded to Oε1 of Glu104 (1.5Å). The C4-O4 bond has an average distance of about
1.6Å. Oε2 of Glu104 receives a hydrogen bond from the 3-NH group (1.6Å). The additional ligands to zinc
include Cys129, Cys132 and His102. Glu91 and Asn89 interact with the 3’-OH group. Right: The X-ray
structure from Ref. 11. (B) The motion of ZEB-H2O in the active site of CDA as a function of time
monitored by the C4-O4 distance (Blue) and C3’-O3’ distance (Red). The distance fluctuations of the C4-O4
bond are significantly larger than those of the C3’-O3’ bond. Also, the C4-O4 bond undergoes transient
bond-breaking and making on a picoseconds scale during the simulations; the bond distance approaches or
exceeds 2.0Å about 2-3% of the times. (C) The free energy (potential of mean force) as a function of the
C4-O4 distance. There is a second minimum near r(C4-O4) = 2Å, corresponding the transient structures with
the relatively long C4-O4 distances observed in Figure III-2A. The free energy difference of the two minima
is about 2.5kcal/mol; the structure with the shorter C4-O4 distance is more stable in the wild-type enzyme.
(D) The fluctuations of the Oε1 (Glu104)...H(O4) (Red) and Oε2 (Glu104)...H3(N3) (Blue) hydrogen bond
distances as functions of time. The average distance for the Oε1...H(O4) hydrogen bond (1.6 Å) is shorter
than that for the Oε2...H3(N3) hydrogen bond (1.75Å), suggesting that the former is more stable. (E) The
average distances for the Oε1...H(O4) (Red), Oε2...H3(N3) (Green) and Zn...O4 (Blue) interactions as
functions of the C4-O4 distance. These average distances are obtained from the trajectories of the umbrella
sampling, and the corresponding free energy information is given in Figure III-2C (See Methods). The
distance that undergoes the most significant change is the Oε1...H(O4) hydrogen bond. This hydrogen bond
is rather strong (based on the hydrogen bond distance) when the C4-O4 covalent bond is intact, but rather
weak when the C4-O4 bond is broken. The distance between O4 and Zn decrease (from 1.95Å to 1.81Å)
with increasing the C4-O4 distance (from 1.5Å to 2.3Å).
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Figure III-3. Simulation results of E104A-ZEB-H2O complex
(A) The dehydration of ZEB-H2O into ZEB and a water molecule observed during the QM/MM MD
simulations of the E104A-ZEB-H2O complex. Left. The early stage of the simulations. The 4-OH group
exists as the zinc hydroxide ion and is on the top of C4 with a C4-O4 distance of about 2.5-3.0Å. Middle.
The next stage of the dehydration. The zinc activated hydroxide oxygen interacts with the 3-NH group and
shares the proton with N3. Right. The final stage of the dehydration. The hydroxide ion has picked up the
proton from N3 and changed to water. It moved back to the initial position on the top of C4. The umbrella
sampling simulations were performed using the difference between r1(O4...H3) and r2(N3-H3) (See Figure
III-3A) as the reaction coordinate (i.e., r1 - r2). The free energy decreases by about 20 kcal/mol as the
proton transfers from 3-N to the hydroxide ion. (B) The dehydration of ZEB-H2O is monitored by the O4H3 (Red), N3-H3 (Blue) and C4-O4 (Green) distances. The O4-H3 distance changes from a distance of 3Å to
1.5Å (i.e., corresponding to the change from the structure on the left to the one in the middle in Figure III3A). It then changes to 1Å (i.e., corresponding to the change to the structure on the right in Figure III-3A),
and at the same time the N3-H3 bond is broken with the corresponding distance increases to about 3Å. (C)
The free energy (potential of mean force) as a function of the C4-O4 distance in the E104A mutant. The
mutation of Glu104 to Ala shifted the minimum of the free energy curve along the C4-O4 bond to the other
location at r(C4-O4) ~ 2.2Å identified earlier (Figure III-2C).
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Abstract
The formation of transition-state analog at the active site of yeast cytosine
deaminase (yCD) is investigated by the quantum mechanical/molecular mechanical
(QM/MM) molecular dynamics (MD) and free energy simulations. It was thought
previously that the binding of the inhibitor pyrimidin-2-one leads to the formation of 4[R]-hydroxyl-3,4-dihydropyrimidine (DHP) at the active of cytosine deaminase.
However, the computational study presented here suggests that the nucleophilic attack by
Zn-hydroxide on the inhibitor is concerted with the two proton transfers from Glu64 to
N3 of the inhibitor and from Zn-OH to Glu64, respectively. This leads to the formation of
a stable alkoxide-like TSA at the active site instead of DHP. It is demonstrated that such
concerted process allows the TSA to be stabilized through a general acid-base
mechanism.

Abbreviations
yCD, yeast cytosine deaminase; TSA, transition state analogues; QM/MM MD
simulations, quantum mechanical/molecular mechanical molecular dynamics simulations;
SCC-DFTB, the self-consistent charge density functional tight-binding method; SD,
stochastic boundary.
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Introduction
General acid-base transition-state stabilization1-4 is one of the most important
strategies that enzymes use to catalyze chemical reactions. Recent computational studies58

suggested that enzymes might use the general acid-base mechanism to promote the

formation of the transition state analog (or tetrahedral intermediate analog) and enhance
their binding affinities at the active sites. One of the cases that have been studied is the
binding of zebularine (ZEB) to cytidine deaminase (CDA) in the formation of a nearperfect transition state analog (TSA). CDA catalyzes the hydrolytic deamination of
cytidine to uridine, and its interaction with the TSA inhibitor has become a paradigm for
studying the tight TSA binding by enzymes. It was previously believed that the strong
electrostatic interactions with the TSA were responsible for the tight binding. However,
the quantum mechanical/molecular mechanical (QM/MM) molecular dynamics (MD) and
free energy simulations8 showed that the nucleophilic attack by the Zn-hydroxide on C4
of ZEB was concerted with two proton transfers from the Zn-hydroxide to Glu104 and
from Glu104 to ZEB, respectively. It was predicted from the computational study that
this concerted process allows the TSA, an alkoxide-like inhibitor instead of zebularine
3,4-hydrate, to be stabilized through a mechanism that is similar to the transition-state
stabilization in the general acid-base catalysis. It would therefore be of interest to
determine the generality of the stabilization of TSAs or tetrahedral intermediate analogs
through the general acid-base mechanism and whether the similar enhancement of
binding also exists in other enzymes.
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In this chapter, we study the formation of TSA in yeast cytosine deaminase
(yCD). yCD catalyzes the deamination of cytosine into uracil with a catalytic mechanism
that is believed to be similar to the cytidine deamination by CDA. We try to determine
whether the stabilization of TSA through the general-acid-base mechanism observed in
the case of CDA in the earlier study also exists for yCD. Cytosine deaminase is one of
the enzymes that are important for the anticancer research. In addition to catalyzing the
deamination of cytosine to uracil (Figure IV-1A), it also catalyzes the conversion of 5fluorocytosine (5-FC) to 5-fluorouracil (5-FU), a compound that is widely used as an
anti-cancer drug.9 The ability of 5-FU to inhibit the DNA synthesis makes it a potent
chemotherapeutic agent for cancer treatments. However, the existence of high
gastrointestinal and hematological toxicities causes a serious problem.10 Fortunately, the
gene-directed enzyme prodrug therapy (GDEPT) can help to lower this risk by utilizing
the less toxic 5-FC as a prodrug.11-12 The CD/5-FC system of GDEPT has been proved
useful in killing tumor cells with minimum toxic effect of 5-FU,13-20 and it was suggest
that the cytosine deaminase from S. cerevisiae (yCD) is more applicable than E. coli
cytosine deaminase (bCD).21 Understanding of the origin of the transition state
stabilization in the yCD-catalyzed reactions is therefore of considerable interest.
The high resolution crystallographic structures of yCDs have been determined
with and without an inhibitor.22 The inhibitor 2-hydroxypyrimidine (2-HP) or its keto
form pyrimidin-2-one that was used in the crystallographic studies is believed to be
hydrated to 4-[R]-hydroxyl-3, 4-dihydropyrimidine (DHP) (see Figure IV-1B) in a
similar process as the hydration of ZEB to form zebularine 3, 4-hydrate in CDA. In our
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it was demonstrated that zebularine 3, 4-hydrate may in fact be

unstable in the active site and that a proton transfer from the Zn-hydroxide group to
Glu104 (the corresponding residue in yCD is Glu64) during the nucleophilic attack could
be related to the very high affinity of TSA. Thus, question remains as to whether the
similar general acid-base mechanism might be involved in the binding of 2-HD or
pyrimidin-2-one by yCD to form TSA. Unfortunately, the location of the proton between
the TSA and Glu64 cannot be clearly identified based on the experimental structures even
at the rather high resolutions (e.g., 1.14 and 1.6Å for yCD). Although computational
studies have been performed on yCD,23 these previous calculations have mainly been
focused on the reaction mechanism and the QM/MM MD and free energy simulations
have not been performed for understanding the possible role of the general acid-base
mechanism in the formation of TSA. We have therefore performed the QM/MM MD and
free energy simulations on the yCD complex in this paper and examined the process of
the interchange between TSA and pyrimidin-2-one in the active site. It is shown that,
similar to the case of CDA, the nucleophilic attack by the Zn-hydroxide group on C4 of
pyrimidin-2-one was found to be concerted with the proton transfers from the Znhydroxide to Oε1 of Glu64 and from Oε2 of Glu64 to pyrimidin-2-one, respectively. The
concerted process of the nucleophilic attack and the proton transfers leads to the
stabilization of the TSA, also an alkoxide-like inhibitor, through the general acid-base
catalysis. Our study of the process of the inhibitor binding in yCD presented here may
provide not only important insights into the role of general acid-base catalysis in the TSA
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stabilization, but also a better understanding of the origin of the transition state
stabilization in the enzyme-catalyzed reaction.

Methods
A fast semi-empirical density-functional approach (SCC-DFTB)24 implemented in
the CHARMM program25 was used for the QM/MM molecular dynamics and free energy
simulations. The SCC-DFTB approach has been extensively tested against high-level
quantum mechanical methods for a range of active site models containing Zn.24 It was
found that the SCC-DFTB approach reproduced structural and energetic properties rather
reliably. Additional tests8 were performed in the earlier study of CDA using several highlevel QM/MM approaches. The QM methods used in the additional tests include
B3LYP/6-31G(d,p) and HF/6-31G(d,p). It was found that the results from the SCCDFTB/MM calculations were similar to those based on the high-level QM methods,
consistent with the study24 on the active site models. For detailed discussions of the
testing results, see Ref. 8 and 24.
The initial coordinates for the simulations were obtained from the crystal
structures of the yCD-TSA complexes (1UAQ at 1.60Å23 and 1P6O at 1.14Å22), which
have the transition state analog bound at the active site. The TSA inhibitor was initially
assumed to be DHP as generally believed, and this assumption was found to be incorrect
(see below). The MD simulations were performed on the yCD-DHP complex. For each of
the two X-ray structures, two models of the yCD complex were constructed. The first
model (referred here as the simple model) has zinc, DHP and the side chain of Glu64
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treated by the QM method and the rest of the system treated by MM using the allhydrogen CHARMM force field (PARAM22).26 With the QM regions expand to the side
chains of Thr86, Cys91 and Cys94, the second model was generated and is referred here
as the bonded model. In this bonded model, several force constants for the bond length
and bond angles related to the zinc cation and its ligands were added in order to
reproduce the structure parameters of the original X-ray structures; these force constants
are given in Table IV-S1. The link-atom approach27 in the CHARMM program was used
to separate the QM and MM regions, and the modified TIP3P water model28,

29

was

applied for the solvent molecules. The initial model systems that were generated from
the X-ray structures containing DHP were found to be unstable; i.e., the proton transfer
from O4 to Oε1 of Glu64 occurred during the QM (SCC-DFTB)/MM energy
minimization, leading to a stable alkoxide-like inhibitor at the active site. The resulting
structures with the alkoxide-like inhibitor were found to be stable during the QM (SCCDFTB)/MM MD simulations. The similar observation was also made during energy
minimizations with use of the HCTH/6-31G** and B3LYP/DZVP treatments for the QM
region. Thus, the simulations suggest that TSA is not DHP, but the corresponding
alkoxide-like species. The high-level QM/MM approaches are extremely time-consuming
for the MD and free energy simulations, and they were therefore not used for the MD and
free energy simulations in the present study. Nevertheless, the similar results obtained
based on the energy minimizations already suggested that DHP might not be stable in the
yCD complex. This situation is similar to that observed for zebularine 3, 4-hydrate in
CDA.8
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The stochastic boundary molecular-dynamics method30 was used for the QM/MM
MD simulations. The system was separated into a reaction zone and a reservoir region,
which was deleted; the reaction zone was further divided into the reaction region and the
buffer region. The reference point for partitioning the system was chosen as the N1 atom
of TSA. The reaction region was a sphere with radius 16Å, and the buffer region has R
equal to 16Å ≤ R ≤ 18Å. Inside the reaction region, the atoms were propagated by
molecular dynamics, whereas atoms in the buffer region were propagated by Langevin
dynamics. The friction constants for the Langevin dynamics were 250ps-1 for the protein
atoms and 62ps-1 for the water molecules. A 1-fs time step was used for integration of the
equations of motion, and the results of the simulations were saved on every 50fs. In
initiating the runs, 500 steps of minimization using the steepest descent method were
performed for the protein and solvent atoms. Then energy minimizations were performed
for the entire stochastic boundary system with the Adapted Basis Newton Raphson
method. The temperature of the system was gradually increased from 50K to 300K (20ps)
and equilibrated at 300K (30ps). The simulations were performed on the resulting
systems for several hundred picoseconds to 1ns.
The umbrella sampling method31 implemented in the CHARMM program along
with the Weighted Histogram Analysis Method (WHAM)32 was used in the present study
and applied to determine the changes of the free energies (potentials of mean force) for
the processes of the nucleophilic attack of the Zn-hydroxide on C4 (monitored by the
distance between C4 and O4). The free energy curves for the simple and bonded models
(see above) led to the same conclusion, and only the results from the simpler model based
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on 1UAQ are presented. The harmonic potentials with a force constant of 50-1000
kcal/mol-Å2 were used for the umbrella sampling of the nucleophilic attack. Twenty
windows were used for the nucleophilic attack by the Zn-hydroxide. For each window,
70ps simulations (20ps equilibration and 50ps production run) were performed with the
origin of the harmonic potential, d0(C4-O4), changed from 1.4Å to 3.0Å leading to a
dataset of 1,000,000 (total) for the free energy analysis. To estimate the effect of the
proton transfer from the Zn-hydroxide to Glu64 on the stability of the TSA, the free
energy profile was also obtained for the nucleophilic attack step with the O4-H bond fixed
by SHAKE algorithm33 at 1.1Å. As a result, Glu64 can still protonate N3 but is unable to
accept the proton from O4.

Results and Discussions
To examine whether the methods of the QM/MM MD simulations used in the
present study are reasonable, the average structures of the active site obtained from the
simulations are compared with one of the structures determined by X-ray crystallography
in Figure IV-2 (PDB ID=1UAQ). The average structures from the simple and bonded
models (see Method) based on the initial coordinates of 1UAQ are shown in Figure IV2B and 2C, respectively, while the average structure of the simple model based on 1P6O
is plotted in Figure IV-2D. All of these average structures are rather close to the X-ray
structures and have the similar hydrogen-bond network and critical distances. It is
interesting to note, however, that in all the average structures Glu-64 has already
accepted the proton from Zn-O4 and becomes protonated during the energy
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minimizations and MD simulations, leading to the alkoxide-like TSA inhibitor. This is in
contrast to the general belief that 4-[R]-hydroxyl-3, 4-dihydropyrimidine (DHP) was
formed in the active site even though the proton is invisible in the experimental
structures. Thus, the QM/MM results indicate that the structure of the yCD-DHP complex
is likely to be unstable and the TSA may exist as an alkoxide-like inhibitor at the active
site (as shown in Fig. 2B-D). This suggestion is supported by the additional high-level
QM/MM calculations (see Methods).
Figure IV-3 monitors the fluctuations of certain distances at the active site of the
yCD complex with the alkoxide-like TSA, including R(C4-O4), R(Zn-O4), R(N3-H3,),
R(Oε2 …H3 ), R(Oε1-H) and R(O4…H). Figure IV-3 shows that the C4-O4 bond is stable
with a bond distance of about 1.5Å (red line in the top panel). Consistent with the average
structures in Figure IV-2B-D, both the Glu64 and N3 are protonated with R(Oε1-H) and
R(N3-H3) around 1Å. The Oε2…H3 (N3) and O4…H distances fluctuate around 2Å,
indicating the formation of two stable hydrogen bonds between Glu64 and the ligand.
To investigate the free energy change associated with the formation of TSA, the
potential of mean force was determined as a function of the C4-O4 distance using the
umbrella sampling method and WHAM program. Figure IV-4 (top) shows that the free
energy of the complex with the alkoxide-like TSA at the active site (i.e., at position B) is
more than 2kcal/mol lower than the substrate analog complex at position A (i.e., the
yCD-pyrimidin-2-one complex). The barrier between A to B is somehow higher than that
in CDA obtained in the earlier simulations.8 Three average active-site structures at A, B
and B’ are plotted in Figure IV-4 (bottom); here B’ is the free energy of the DHP
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complex with the proton transfer from Zn-hydroxide to Glu64 prevented by use of the
SHAKE algorithm.33 The yCD-pyrimidin-2-one complex before the nucleophilic attack
(i.e., with C4-O4 distance at about 2.4 Å) was found to be stable during the 500ps
QM/MM MD simulations, although Glu64 underwent some rotation. At position B, the
transition state analog is formed with the average bond length of C4-O4 about 1.5 Å and
the hydrogen of the zinc hydroxide is transferred to Glu64, as discussed earlier. As can be
seen from Figure IV-4, the shapes of the two free energy curves are essentially the same
in the area of d0(C4-O4) ≥ 2Å. This result is expected, as the O4-H bond is intact in the
early stage of the nucleophilic attack and the corresponding structures along the reaction
coordinate in the two cases are similar. Figure IV-4 also shows that the free energy after
the nucleophilic attack is much higher for the curve with the constraint (i.e., at B’) than
that without (i.e., at B). The major difference for the two free energy simulations is that
the ligand in the complex at B’ is DHP, while it is the alkoxide-like TSA at B. Thus, it
appears that a major stabilization of the alkoxide-like TSA complex in the active site
compared to that of DHP arises from the proton transfer from the Zn-hydroxide to Glu64.
The H3 proton transfer is monitored by the changes of distances R(N3-H3) (blue)
and R(Oε2-H3) (red) in Figure IV-5A based on the trajectories from the free energy
simulations as d0(C4-O4) (the reaction coordinate in the free energy simulations) changes
from 1.95Å (upper panel) to 1.85Å (lower panel). Accordingly, the H proton transfer is
monitored by the changes of R(O4-H) (blue) and R(Oε1-H) (red) in Figure IV-5B. Figure
IV-5A (Figure IV-5B) shows that the positions of the blue and red lines are reversed from
the upper panel to the lower panel, indicating that H3(H) is transferred near the transition
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state of the nucleophilic attack that occurs between d0(C4-O4) = 1.95Å and 1.85Å (see
Figure IV-4). Figure 6 shows the average distances of r(O4…H) (blue), r(Oε1-H)
(magenta), r(Oε2…H3) (red) and r(N3-H3) (yellow) as a function of d0(C4-O4) from the
umbrella sampling. It is of interest to note that all the curves seem to cross with each
other near the transition state, suggesting a concerted process of the nucleophilic attack
and proton transfers as shown by the solid arrow from I to IV in Figure IV-1C.
It is believed that the binding of pyrimidin-2-one to CD leads to the formation of
4-[R]-hydroxyl-3,4-dihydropyrimidine (DHP) through the nucleophilic attack of Znhydroxide on the inhibitor. However, the proton on the C4-OH group is invisible in the Xray structures. Here we showed from the QM/MM MD simulations that a stable DHP
would not exist in the active site of yCD and that the corresponding alkoxide-like
structure would be more stable for which the proton on the C4-OH group is transferred to
Glu64. This alkoxide-like TSA complex cannot be distinguishable from that of DHP in
the X-ray structures. Therefore, our prediction is still consistent with the experimental
structures. The free energy simulations for the nucleophilic attack process showed that
the proton transfer from Zn-hydroxide to Glu64 plays an important role in stabilizing the
TSA complex and the DHP complex is even less stable than the pyrimidin-2-one
complex (i.e., before the nucleophilic attack).

Conclusions
The formation of transition-state analog at the active site of yCD was investigated
by the QM/MM MD and free energy simulations. Similar to our earlier simulations on
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the binding of ZEB to CDA,8 DHP was found to be unstable at the active site of yCD. It
was suggested that the nucleophilic attack by the Zn-hydroxide group on C4 of the
inhibitor may be concerted with two proton transfer processes (from Glu64 to N3 and
from O4 to Glu64, respectively), leading to the formation of a stable alkoxide-like TSA at
the active site. Such concerted process seems to allow the TSA to be stabilized through a
general acid-base mechanism. For some of the nucleophilic attack processes (e.g., by ZnOH- or Zn-OH2) in enzyme-catalyzed reactions, the general acid-base mechanisms are
not invoked to explain the efficiency of the reactions. It would be of interest to examine
whether the tetrahedral intermediates resulting from the nucleophilic attacks could also
be stabilized by the general acid-base mechanisms as we demonstrated for the inhibitor
binding in CDA and CD.
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Figure VI-1. The reaction catalyzed by yCD and the formation of TSA in yCD
(A) The deamination of cytosine to uracil catalyzed by yCD. A tetrahedral intermediate is believed to be
formed. (B) 2-hydroxypyrimidine (2-HP) or its tautomeric keto form pyrimidin-2-one is hydrated by yCD
and 4-[R]-hydroxyl-3,4-dihydropyrimidine (DHP) is believed to be formed at the active site. (C) The
possible steps for the TSA formation in yCD which may be concerted or step-wise. IÆII: protonation of N3;
IIÆIII: nucleophilic attack of Zn-hydroxide on C4; IIIÆIV: the proton transfer from O4 to Oε1 (Glu64). A
concerted IÆIV process is suggested from our QM/MM MD and free energy simulations.
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Figure IV-2. Comparison of yCD-TSA complexes between the average structures
from the simulations and the X-ray structure
The hydrogen bond distances are between non-hydrogen atoms in the X-ray structure but not in the average
structures. The ligations with zinc are also indicated. (A) The X-ray structure of 1UAQ. (B) The average
structure of the simple model (see Methods) from the simulations of the yCD complex based on 1UAQ. (C)
The average structure of the bonded model based on 1UAQ. (D) The average structure of the simple model
based on the X-ray structure of 1P6O.
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Figure IV-3. The distance fluctuations in simulations of yCD-TSA complex
The distance fluctuations were obtained from 1 ns simulations of the simple model of the yCD-DHP
complex based on the structure of 1UAQ. Top panel: R(C4-O4) (red line) and R(Zn-O4) (blue line); Middle
panel: R(N3-H3) (red line) and R(Oε2…H3) (blue line); Bottom panel: R(Oε1-H) (red line) and R(O4…H)
(blue line). See Figure IV-1B for the atom designations.
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Figure IV-4. The nucleophilic attack in the yCD-TSA complex
Top: The potentials of mean force for the nucleophilic attack with (blue and dashed line) and without (red
and solid line) the constraint on the O4-H bond (see Methods). The labels A and B (B’) indicate the
different stages before and after the nucleophilic attack. The corresponding active-site structures are given
in the figures below. Bottom: The active site structures at the different stages of the nucleophilic attack. (A)
Before the nucleophilic attack. The arrow indicates that the side chain of Glu64 is flexible. (B) The
formation of TSA. (B’) The formation of DHP with addition of a constraint on the O4-H bond.
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Figure IV-5. The proton transfers monitored by the changes of the distances
(A) The H3 proton transfer monitored by the distances N3-H3 (blue) and Oε2-H3 (red) before [upper panel
with R(C4-O4)=1.95 Å] and after [lower panel with R(C4-O4)=1.85 Å] the transition state of nucleophilic
attack; (B) The H (O4) proton transfer monitored by the distances O4-H (blue) and Oε1-H (red) before
(upper panel) and after (lower panel) the transition state of nucleophilic attack.

Chapter IV

95
3.5

O4-H
Oε1-H

distances (Å)

3

Oε2-H3
N3-H3

2.5
2
1.5
1
0.5
1.4

1.6

1.8

2

2.2

2.4

r(C4-O4) (Å)
Figure IV-6. The changes of the distances during the nucleophilic attack
The average distances of R(O4-H) (blue), R(Oε1-H) (magenta), R(Oε2-H3) (red) and R(N3-H3) (yellow) as a
function of the C4-O4 distance obtained from the free energy simulations.
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Table IV-S1. Parameters for the zinc-bonded model
Top: bond-length parameters; Bottom: bond-angle parameters. See Figure IV-S1 for labeling.

Figure IV-S1. The structure of zinc ligation in the bonded model
The transition state analogue is shown in stick while the residues of yCD are shown in ball and stick. The
labeling of the atoms around the zinc atom are same to those in Table IV-S1.
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Figure IV-S2. Comparison of the performances of the SCC-DFTB and B3LYP/631G(d,p) methods
Comparison of the free energy changes between different complexes along the corresponding reaction
coordinates from the SCC-DFTB (red) and B3LYP/6-31G** (blue) calculations, respectively. For the
structures of I, II, III and IV, see Figure IV-1C. Energy minimizations were performed at the SCC-DFTB
level and single point B3LYP/6-31G** calculations were undertaken at the SCC-DFTB geometries. The
structure IV is the most stable structure in all the cases. (A) Between I and IV; (B) Between II and IV; (C)
Between III and IV.
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Figure IV-S3. Comparison of the free energy changes of the nucleophilic attack
starting from different initial structures
The free energy (potential of mean force) curves are of umbrella sampling simulations starting from
different initial structures obtained from the MD simulations (e.g., at 400ps, 450ps, 500ps, 550ps, 700ps
and 800ps), including a correction based on the energy differences from the SCCDFT and B3LYP/6-31G**
calculations on model systems. The results show that the relative free energy of the alkoxide-like TSA
complex (IV) would be even lower and the complex would be relatively more stable compared to the
complex I if a correction based on a high level QM method was introduced into the SCC-DFTB free energy
curves (see Figure IV-4). This is because that SCC-DFTB underestimates the stability of the alkoxidelike
TSA complex (see Figure IV-S2A). In addition, the similar free energy curves obtained suggest that the
results are not sensitive to the initial structures used in the PMF simulations.
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Figure IV-S4. The free energy changes for the proton transfer between O4 and Oε1
During the QM(SCC-DFTB)/MM simulations for the transfer of H between O4 and Oε1 (Figure IV-1C,
between III and IV), a constraint has been added on the C4-O4 bond to prevent it from being broken. The
free energy difference between B and B’ is similar to that between B and B’ obtained from the nucleophilic
attack and reported in Figure IV-4.
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The Importance of Dynamics in SubstrateAssisted Catalysis and Specificity
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Abstract
The QM(SCC-DFTB)/MM(CHARMM) molecular dynamics (MD) and free
energy simulations have been performed on the nucleophilic attack by Ser278 of
kumamolisin-As on a 5 amino acid peptide RPXaa*FR, in order to study the origin of the
catalytic activity and specificity of this enzyme. The aspartic acid residue, Asp164 seems
to act as a general acid catalyst to protonate and stabilize the tetrahedral intermediate,
assisting in the nucleophilic attack. At the same time, a significant rotation of the P1-His
side chain was observed, with the formation of a salt bridge with the deprotonated
Asp164, which may give help to the function of Asp164. The effect of P1-His seems to be
dynamic substrate-assisted catalysis (SAC).

Abbreviations:
SAC, substrate-assisted catalysis; QM/MM Quantum mechanical/molecular
mechanical; MD molecular dynamics; TI, Tetrahedral intermediate; PMF, potential of
mean force; SCC-DFTB, self consistent charge density-functional tight-binding; WHAM,
weighted histogram analysis method.
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Introduction
Substrate-assisted catalysis (SAC) is the process in which one or more functional
groups from the substrate, in addition to those from the enzyme, contribute to the rate
acceleration for the enzyme-catalyzed reaction. There is growing evidence that SAC may
exist in many naturally occurring or engineered catalysts.1-2 The existence of productassisted catalysis has also been suggested recently.3 Understanding the role of SAC in
enzyme specificity is of considerable interest, as it may provide new insights into how
substrates compete with each other for enzymes. Many of the previous studies of SAC1-2
have focused on the catalytic effects resulting from the well-positioned substrate groups
that can participate in SAC directly, without undergoing significant conformational
changes. A fundamental question is whether some substrate groups which are not located
at such ideal positions in enzyme-substrate complexes would be able to undergo
conformational changes and participate in SAC as well. In this chapter, we report the
results of computer simulations and show that the dynamics involving distant substrate
groups may indeed play an important role in SAC. The importance of this type of SAC
involving conformational changes of substrates might have been overlooked in some
enzymes due in part to the dynamic nature of the effects that may not be well reflected in
the X-ray structures.
The system used to demonstrate the importance of dynamics in substrate-assisted
catalysis is kumamolisin-As, a member of a recently characterized sedolisin family of
proteolytic enzymes.4-7 The QM(SCC-DFTB)/MM(CHARMM) molecular dynamics
(MD) and free energy simulations have been performed in this study.8 Sedolisins have a
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fold resembling that of subtilisin and a maximal activity at low pH (~3.9).4-5 The defining
features of kumamolisin-As and other members of this family are a unique catalytic triad,
Ser278-Glu78-Asp82 (kumamolisin-As numbering), as well as the presence of an
aspartic acid residue, Asp164, in the active site. Asp164 replaces Asn155 of subtilisin, a
residue that creates the oxyanion hole.6 Unlike Asn155 that provides hydrogen bonds to
stabilize the oxyanion of the tetrahedral intermediate during the catalysis by subtilisin,6
Asp164 seems to act as a general acid catalyst to protonate the tetrahedral intermediate
and assist in the nucleophilic attack by Ser278 of kumamolisin-As.7 The substrates used
in the present work are RPXaa*FR (here * designates the scissile peptide bond and Xaa
denotes the residue at the P1 site). The formation of the tetrahedral intermediate (TI) is
examined, as the efficiency of this step of the reaction is crucial for high substrate
specificity of proteolytic enzymes.6 The models were built using the X-ray structure of
kumamolisin-As complexed with an inhibitor N-acetyl-isoleucyl-prolyl-phenylalaninal
(AcIPF)5b and the substrate coordinates were obtained based on those from the
corresponding residues in the Ser278Ala mutant of pro-kumamolisin.5f We demonstrate
that there is a conformational transition of the His residue at the P1 site for RPH*FR and
that a salt bridge is formed between His and Asp164 as the system changes from the
substrate to the TI complex. It is suggested that this conformational change and the
formation of the salt bridge make it possible for the His residue to participate in SAC
during the formation of the tetrahedral intermediate. Our suggestion for the existence of
dynamic SAC is supported by the comparison of the free energy profiles of the TI
formation for RPH*FR and RPF*FR.
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Results and Discussions
The average structures of the active site of the kumamolisin-As complex during
the nucleophilic attack by Ser278 on the RPH*FR substrate are given in Figure V-1. As is
evident from Figure V-1A, Ser278 is well aligned for the nucleophilic attack on C in the
substrate complex. Glu78 and Asp164 are well positioned to act as the general base and
acid catalysts, respectively, to assist in the nucleophilic attack. His at the P1 site forms
two hydrogen bonds (H-bonds) to the C=O group of Pro at P2 and the carboxylate of
Asp179, respectively. Moreover, there is an H-bond between the backbone N-H group of
the P1 residue and Glu78. Figure V-1B shows that the interaction of the His sidechain
with the C=O group is significantly weakened as the nucleophilic attack proceeds to the
transition state, while the H-bond with Asp179 remains intact. The weakening of this
interaction involving His seems to be triggered by the breaking of the H-bond between
the backbone N-H group at P1 and Glu78, as Glu78 accepts the proton from Ser278 and
becomes uncharged during the nucleophilic attack. Thus, there appear to be the
cooperative effects of hydrogen bonding16 in the stabilization of the H-bond between the
His sidechain and the P2 C=O group in the substrate complex. Figure V-1C shows that
the histidine sidechain rotated significantly (mainly around the Cβ―Cγ bond) to interact
with the unprotonated Asp164 residue during the formation of the TI complex. Since
Asp164 is the general acid catalyst,7 the formation of the salt bridge between His and
Asp164 may make the TI complex more stable (see below).
The changes of free energy (potential of mean force) as functions of the reaction
coordinate (ξ) for the nucleophilic attack by Ser278 on the RPH*FR and RPF*FR
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substrates are given in Figure V-2. The free energy change for the RPH*FR complex in
which the proton on Asp164 is fixed by the SHAKE algorithm19 (to prevent Asp164 to
act as the general acid) is also given. Figure V-2 shows that the free energy barrier of the
TI formation is ~ 15 kcal/mol for RPH*FR, and this barrier increases to ~ 20 kcal/mol
when the substrate is changed to RPF*FR. The major structural difference for the two
substrates in the TI complexes is that His at the P1 site in RPH*FR is able to form a salt
bridge with Asp164 through a conformational transition (see above), and this salt bridge
may help to stabilize the charge formation on Asp164 and make it a better general acid.
In contrast, Phe at P1 for RPF*FR is unable to interact with Asp164 and the stabilization
of the TI through this mechanism is therefore impossible. It is of interest to note that the
TI for RPH*FR becomes considerably less stable when the proton transfer from Asp164
to the ligand is prevented by using the SHAKE algorithm, supporting the suggestion that
Asp164 acts as a general acid catalyst.7
The results of the simulations reported here are consistent with the available
experimental data.5 It has been shown that kumamolisin-As can cleave the –Pro–
Xaa*Yaa– sequence and that this enzyme generally has higher specificity for the
substrates with a positively charged residue at the P1 site than for those without such a
residue. For instance, it was found that the kcat (KM) value for a substrate containing the –
Pro–Arg*Gly– sequence is ~ 65-fold (~ 6.5-fold) higher than for a substrate containing
the

–Pro–Gly*Gly– sequence, leading to 10-fold increase of kcat/KM.5a Moreover, a

specificity profile analysis5b using a peptide library showed that kumamolisin-As
generally displays higher specificity for the substrates with His, Lys or Arg at P1 than for

Chapter V

106

the other substrates. Quantitative comparisons of the experimental data and theoretical
results require determinations of the catalytic mechanism and rate limiting step which are
poorly understood.
We suggest that the dynamics may play an important role in SAC and specificity
of kumamolisin-As. The conformational change observed is triggered by the
deprotonation/protonation events during the general acid-base catalysis. It is of interest to
examine whether this would also occur for other enzymes.

Supporting Information: Computational Method
A fast semi-empirical density-functional approach (SCC-DFTB)10 recently
implemented in the CHARMM program11 was used for quantum mechanical/molecular
mechanical (QM/MM) molecular dynamics (MD) and free energy (potential of mean
force or PMF) simulations. The initial coordinates of the enzyme were obtained from the
crystal structure (PDB ID:1SIO. Resolution: 1.80 Å) of kumamolisin-As complexed with
the inhibitor AcIPF (N-acetyl-isoleucylprolyl- phenylalaninal).5b The coordinates of the
RPH*FR substrate were obtained from the crystal structure of the Ser278Ala mutant of
pro-kumamolisin (PDB ID: 1T1E. Resolution 1.18 Å) which contains an activation
peptide/linker running through the active site cleft. The catalytic domain of the
Ser278Ala mutant of pro-kumamolisin has a virtually identical structure compared to the
active kumamolisin.5f Kumamolisin-As and kumamolisin have a high sequence identity
(92.7%), and their structures can be superimposed very well.5b The structures of the
kumamolisin-As complex and the catalytic domain of the Ser278Ala mutant of pro-
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kumamolisin were superposed, and the coordinates of the P3-Arg169p―P2-Pro170p―P1His171p―P1’-Phe172p―P2’-Arg173p peptide fragment from the linker were used to
generate the structures of the RPH*FR substrate and the kumamolisin-As―RPH*FR
complex; the backbone of P3-Arg169p―P2-Pro170p―P1-His171p was superimposed
with the inhibitor AcIPF very well. The structure of the kumamolisin-As―RPF*FR
complex was generated simply by replacing His at P1 by Phe; the Phe residue at the P1
site of RPF*FR occupies essentially the same position as Phe of AcIPF in the X-ray
structure of the kumamolisin-As―AcIPF complex.
The stochastic boundary molecular dynamics method9 was used for QM(SCCDFTB)/MM(CHARMM) simulations. The system was separated into a reaction zone and
a reservoir region; the reaction zone was further divided into the reaction region and
buffer region. The reaction region was a sphere with radius R of 16 Å, and the buffer
region had R equal to 16 Å ≤ R ≤ 18 Å. The reference center for partitioning the system
was chosen to be the C atom of the His (Phe) carbonyl at P1 of the substrate (Figure V1A). The resulting system contains 3454 atoms (2522 enzyme atoms, 107 substrate atoms
and 275 water molecules). The backbone of the substrates starting from the C atom of Pro
at P2 to the Cα atom of Phe at P1’ was treated by QM along with the side chains of Glu32,
Asp82, Glu78, Ser278 and Asp164. The rest of the system was treated by MM. The allhydrogen potential function (PARAM22)12 was used for MM atoms. The link atom
approach17, 18 was used to separate the QM and MM regions. A modified TIP3P water
model13 was employed for the solvent. The initial structure for the entire stochastic
boundary system was optimized by adopted basis Newton-Raphson (ABNR) method.
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The system was gradually heated from 50 to 300 K in 20 ps, and equilibrated at 300 K for
30 ps. A 1-fs time step was used for integration of the equations of motion, and the
coordinates were saved every 50 fs for analyses. For the atoms in the buffer region, the
Langevin Dynamics (LD) frictional constants were 250 ps-1 for the protein atoms and 62
ps-1 for the water molecules. The bonds involving hydrogen atoms in the MM region
were fixed by the SHAKE algorithm.19 The QM/MM MD simulations were performed
for about 1 ns for the substrate complexes. The tetrahedral complexes were found to be
unstable, and the C-Oγ bond was broken during the simulations, leading to the substrate
complexes.
The umbrella sampling method14 implemented in the CHARMM program along
with the Weighted Histogram Analysis Method (WHAM) 15 was applied to determine the
changes of the free energy (potential of mean force). The free energy curves for the wildtype enzyme (with and without the QM treatment of D164) complexed with the RPH*FR
and RPF*FR substrates were obtained as functions of ξ = r(C-Oγ) for the nucleophilic
attack by Ser278 on the C atom of the substrate between His (Phe) at P1 and Phe at P1’ to
form the tetrahedral intermediate. Harmonic biasing potentials were defined by the RESD
module of CHARMM, with force constants in range of 100~800 kcal·mol-1·Å-2. The
statistical error of the free energy simulations20 was estimated to be about ± 0.6 kcal/mol.
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Figure V-1. Average structures of kumamolisin-As complex during the nucleophilic
attack
Average structures of kumamolisin-As complex during the nucleophilic attack by Ser278 on substrate
RPH*FR obtained from the QM/MM MD and free energy simulations. The enzyme is plotted in ball and
stick and the ligand in stick. Hydrogen bonds (H-bonds) are indicated by red dashed lines. Ser278-Glu78Asp82 is the catalytic triad. Only the side chain of the P1 (His) residue for the substrate is shown for clarity.
(A) The substrate complex. His side chain at P1 donates an H-bond to the C=O group of Pro at P2, in
addition to the carboxylate of Asp179. Glu78 accepts an H-bond from the backbone N-H group of the P1
residue (the H-bond distance shown here is between the non-hydrogen atoms). (B) An average structure
near the transition state of the nucleophilic attack. The interaction of the His sidechain with the C=O group
is significantly weakened and the H-bond between Glu78 and the N-H group is broken. (C) The TI
complex. His at P1 has undergone a conformational change to interact with the unprotonated Asp164
residue and the H-bond to the C=O group observed in the substrate complex is broken.
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Figure V-2. The free energy changes of the nucleophilic attacks
The free energy changes from the substrate to TI complex as a function of ξ = r(C–Oγ), the reaction
coordinate for the nucleophilic attack. Red solid line: the RPH*FR substrate without use of the SHAKE
algorithm; Orange dot-dashed line: the RPH*FR substrate with use of the SHAKE algorithm to fix the
proton on Asp164; Green dashed line: the RPF*FR substrate.
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Figure V-S1. The average structure of the substrate complex for RPH*FR
The average structure of the substrate complex for RPH*FR obtained from MD simulations. The enzyme is
plotted in ball and stick and the substrate in stick. Hydrogen bonds are indicated by red dashed lines.
Ser278-Glu78-Asp82 is the catalytic triad. The S1 binding pocket is formed by Ala161, Gly163, Gly130,
Thr277 and Asp179, as in the X-ray structure of the kumamolisin-As-AcIPF complex. Only the sidechains
of the P1 (His) and P1’ (Phe) residues of the substrate are shown for clarity.
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Figure V-S2. The average structure of the transition state complex for RPH*FR
The average structure at r(C-Oγ) = 1.75 Å (i.e., near the transition state) for the RPH*FR complex during
the nucleophilic attack obtained from the free energy simulations.

Figure V-S3. The average structure of the TI complex for RPH*FR
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Figure V-S4. The average structure of the substrate complex for RPF*FR

Figure V-S5. The average structure of the TI complex for RPF*FR
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simulations of the acylation reaction catalyzed by
the serine carboxyl peptidase kumamolisin-As
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Abstract
Quantum mechanical/molecular mechanical molecular dynamics and free energy
simulations are performed to study the acylation reaction catalyzed by kumamolisin-As, a
serine-carboxyl peptidase, and to elucidate the catalytic mechanism and the origin of
substrate specificity. It is demonstrated that the nucleophilic attack by the serine residue
on the substrate may not be the rate limiting step for the acylation of the GPH*FF
substrate. The present study also confirms the earlier suggestions that Asp164 acts as a
general acid during the catalysis and that the electrostatic oxyanion-hole interactions may
not be sufficient to lead a stable tetrahedral intermediate along the reaction pathway.
Moreover, Asp164 is found to act as a general base during the formation of the acylenzyme from the tetrahedral intermediate. The role of dynamic substrate assisted
catalysis (DSAC) involving His at the P1 site of the substrate is examined for the
acylation reaction. It is demonstrated that the bond breaking and making events at each
stage of the reaction trigger a change of the position for the His sidechain and lead to the
formation of the alternative hydrogen bonds. The back and forth movements of the His
sidechain between the C=O group of Pro at P2 and Oδ2 of Asp164 in a ping-pong-like
mechanism and the formation of the alternative hydrogen bonds effectively lower the free
energy barriers for both the nucleophilic attack and the acyl-enzyme formation and may
therefore contribute to the relatively high activity of kumamolisin-As towards to the
substrates with His at P1 site.
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Abbreviations:
DSAC, Dynamic substrate assisted catalysis; SAC, substrate-assisted catalysis;
QM/MM Quantum mechanical/molecular mechanical; MD molecular dynamics; TI,
Tetrahedral intermediate; PMF, potential of mean force; SCC-DFTB, self consistent
charge density-functional tight-binding; TS, transition state; WHAM, weighted histogram
analysis method.
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Introduction
Kumamolsin-As belongs to the recently characterized family of serine-carboxyl
peptidases (sedolisins) that were originally described by Murao, Oda and co-workers
about 20 years ago.

1-3

Sedolisins are present in a wide variety of organisms, including

archaea, bacteria, molds, slime molds (mixomycetes), amoebas, fishes, and mammals,
and they are active at low pH and often high temperature. This family of enzymes seems
to have been derived through divergent evolution from a common ancestor with classical
serine peptidases; the structural studies 4-10 showed that sedolisins have a fold resembling
that of subtilisins, although they are significantly larger (the mature catalytic domains
contain approximately 375 amino-acid residues). One interesting question is why Nature
needs another family of subtilisin-like peptidases. For bacterial sedolisins, one possible
explanation is that some organisms might have to utilize such evolved serine-carboxyl
peptidases for their survival, presumably under acidic environments and high
temperature. The biological importance of sedolisins in mammals has already been
demonstrated by the fact that mutations leading to the loss of the human enzyme CLN21113

, another member of the sedolisin family, result in a fatal neurodegenerative disease,

classical late-infantile neuronal ceroid lipofuscinosis.14
The three-dimensional structures are available for three members of the sedolisin
family, including sedolisin (also known as pepstatin-insensitive carboxyl proteinase or
PSCP)

4-6

, kumamolisin

7-8

, and kumamolisin-As

9-10

. The defining features of these

enzymes are a unique catalytic triad, Ser-Glu-Asp (Ser278-Glu78-Asp82 for
kumamolisin-As; see Figure VI-1A), as well as the presence of an aspartic acid residue
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(Asp164 for kumamolisin-As) that replaces Asn155 of subtilisin, a residue that creates
the oxyanion hole in the classical subtilisin-like serine peptidase. The X-ray
crystallographic and mutagenesis studies

4-10

demonstrated that the serine residue is the

catalytic nucleophile for sedolisins, while the nearby Glu is likely to act as the general
base to accept the proton from Ser and assist in the nucleophilic attack. Recent
computational studies

15-17

further suggested that Asp164 may act as a general-acid

catalyst to protonate the substrate and stabilize the tetrahedral intermediate (TI). This
mechanism of the TI stabilization is similar to the one proposed for aspartic peptidases18,
but is different from that of serine peptidases, in which the electrostatic oxyanion-hole
interactions are used instead

19

. Thus, although sedolisins might have evolved from a

common precursor of classical serine peptidases, they seemed to have ended up with the
use of some of the chemistry of aspartic peptidases for the catalysis. The existence of
significant mechanistic similarities between sedolisins and both serine and aspartic
peptidases makes the detailed understanding of this newly characterized family of
enzymes extremely interesting.
Here we examine the acylation reaction catalyzed by kumamolisin-As of the
GPH*FF substrate (* designates the scissile peptide bond), using quantum
mechanical/molecular mechanical (QM/MM) molecular dynamics (MD) and free energy
(potential of mean force) simulations. Although the enzyme has been a subject of
previous computational studies 15-17, the earlier investigations have mainly focused on the
inhibitor binding and the nucleophilic attack by Ser278. To the best of our knowledge, a
detailed examination of the acylation reaction as well as the corresponding free energy
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barriers has not been performed for this enzyme, or indeed for any sedolisins.
Kumamolisin-As can cleave the –Pro–Xaa*Yaa– sequence (here Xaa and Yaa denote the
residues at the P1 and P1’ sites, respectively). One experimental observation that is of
considerable interest is the fact that this enzyme generally has higher specificity for the
substrates with a positively charged residue at the P1 site than for those that do not carry
such charge 3, 9. For instance, it was found that the kcat value for a substrate containing the
–Pro–Arg*Gly sequence is ~ 65-fold higher than for a substrate containing the –Pro–
Gly*Gly sequence and KM ~ 6.5-fold higher, leading to 10-fold increase of kcat/KM (3).
The higher specificity for the substrates with a positively charged residue at P1 was also
confirmed from specificity profile analysis using a peptide library

18-20

. It was suggested

in our earlier computational study16 that the dynamics involving His at P1 triggered by the
bond breaking and making events may play an important role in the stabilization of the
tetrahedral intermediate and therefore contribute to the relatively high specificity for the
substrates with His at P1. This type of catalytic processes is normally referred to as
substrate-assisted catalysis (SAC)

21

, with one or more functional groups from the

substrate, in addition to those from the enzyme, contributing to the rate acceleration for
the enzyme-catalyzed reaction. However, many of the previous studies of SAC

22

have

focused on the catalytic effects resulting from the well-positioned substrate groups that
can participate in SAC directly, without undergoing significant conformational changes.
A major difference in the case of kumamolisin-As is that His at the P1 site is not located
at such an ideal position in the enzyme-substrate complex, but is able to undergo a
conformational change for the TI stabilization during the nucleophilic attack. We define
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this type of SAC involving conformational changes of the substrates as dynamic SAC
(DSAC), to distinguish it from the standard SAC for which the conformational changes
of the substrate are not required. It is shown here that such DSAC involving His at P1 also
plays an important role for the acyl-enzyme formation. The importance of DSAC or
similar types of catalytic processes involving the conformational changes of protein
groups triggered by the bond breaking and making events might have been overlooked in
some other enzymes, due in part to the dynamic nature of the effects that may not be well
reflected in the X-ray structures.
Here we demonstrate that the nucleophilic attack by the serine residue on the
substrate may not be the rate limiting step for the acylation reaction for kumamolisin-As,
which is different from some previous calculations on classical serine peptidases 20. The
results support our earlier conclusion that the general acid mechanism involving Asp164
is crucial for the stabilization of the tetrahedral intermediate during the catalysis and that
the electrostatic oxyanion-hole interactions may not be sufficient to generate a stable TI
along the reaction pathway

15-17

. Moreover, Asp164 is found to act as a general base

during the formation of the acyl-enzyme from the tetrahedral intermediate, and therefore
plays multiple roles in the catalysis. The present study also provides important new
insights into the role of DSAC. The previous suggestion

16

for the existence of DSAC

was based on the results of the nucleophilic attack on a substrate (RPH*FR). Since the
nucleophilic attack may not be rate limiting for the acylation (see above), a question
remains as to whether the dynamics involving the His residue at P1 would also play a role
in stabilizing the transition state for the acyl-enzyme formation (so that an overall rate
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enhancement for the acylation reaction could be achieved). In this paper, it is shown that
the bond breaking and making events at the different stages of the acylation reaction
trigger the back and forth movements of the His sidechain at P1 between the C=O group
of Pro at P2 and Oδ2 of Asp164, leading to the formation of the alternative hydrogen
bonds and the reduction of the free energy barriers for both the nucleophilic attack and
formation of the acyl-enzyme. It is proposed that such motions and the formation of the
alternative hydrogen bonds may contribute to the relatively high activity of kumamolisinAs towards the substrates with His at the P1 site and lead to the reduction of the free
energy barriers for the de-acylation reaction as well.

Methods
A fast semi-empirical density-functional method (SCC-DFTB) 23 implemented in
the CHARMM32b program

24

was used in the present study for the QM/MM molecular

dynamics (MD) and free energy (potential of mean force or PMF) simulations. The
efficiency of the semi-empirical QM methods (such as SCC-DFTB) makes possible to
sample millions of the structures and conformations for enzyme systems and to determine
the free energy profiles of the enzyme-catalyzed reactions. These important tasks for
understanding enzymes are not feasible with high-level first-principle ab initio methods.
Moreover, recent testing studies and comparisons with high-level ab initio QM methods
on model systems seem to indicate that the SCC-DFTB method offers certain advantages
over some other semi-empirical QM methods 25-27. However, it should be pointed out that
care must be exercised in using the semi-empirical QM methods for the studies of
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enzymes. Indeed, while the high-level QM/MM approaches based on energyminimization may face the intrinsic problem for the lack of sampling sufficient
conformational spaces, the accuracy of the semi-empirical QM/MM MD and free energy
simulations may be limited by the approximations in their descriptions of the breaking
and formation of chemical bonds as well as interactions. For instance, the deficiencies of
the SCC-DFTB method used here could affect some of the conclusions reached from this
study (even though the SCC-DFTB energies are not used directly to generate the
profiles). Thus, the comparisons of performance of the SCC-DFTB method on certain
models as well as on simplified enzyme systems with those from high-level ab intio
calculations are of fundamental importance. This would allow us to obtain important
insights into the question as to whether the conclusions obtained from the QM/MM MD
and free energy simulations could still hold if high-level QM methods would be used.
Although the SCC-DFTB method has been tested on a large number of models
and enzyme systems

25-27

, additional comparisons with the results from high-level ab

initio calculations for the systems related to the present study are necessary. In our earlier
work 15, we compared the performance of the QM(SCC-DFTB)/MM simulations with the
calculations based on the QM(B3LYP/6-31G**)/MM energy minimization for the
process of the nucleophilic attack of Ser278 on an inhibitor N-acetyl-isoleucyl-prolylphenylalaninal (AcIPF) in the kumamolisin-As complex. We found that the results from
the both methods are consistent with each other concerning the role of Asp164 and Glu78
as the general acid-base catalysts. There are two additional conclusions obtained from the
present study that could also be affected by possible deficiencies of SCC-DFTB. One
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conclusion is that the nucleophilic attack by Ser278 on the substrate may not be rate
limiting for the acylation reaction and the other is the existence of dynamic substrate
assisted catalysis (DSAC). The first conclusion could be affected if the SCC-DFTB
method underestimates (overestimates) the activation barrier for the nucleophilic attack
more (less) significantly than the activation barrier for the acyl-enzyme formation (i.e.,
the breaking of the peptide bond). In this case, the relatively low barrier for the
nucleophilic attack might be simply due to the deficiencies of SCC-DFTB. We have
compared the performance of SCC-DFTB with B3LYP/6-31G** on a small model
system and on selected snapshots of the enzyme complex. It was found that the SCCDFTB method may in fact underestimate the activation barrier for the acyl-enzyme
formation more significantly than that for the nucleophilic attack. Thus, the first
conclusion mentioned above is likely to be true even with the high level ab initio method.
For the conclusion concerning the existence of DSAC, the high-level ab initio MD
simulations could not be performed due to the reason that these simulations are extremely
expensive. In order to confirm this conclusion, we changed the treatment of His at P1
from SCC-DFTB to MM 29. The same conformational transition involving His at P1 was
also observed, confirming our conclusion of the existence of DSAC.
There are additional questions that need to be mentioned for the model building
processes. The family of sedolisins is only active at low pH, and the models used in the
present study (e.g., the information concerning the protonation states of Asp and Glu
residues) were based on the computer models of the tetrahedral adduct complex obtained
in the earlier studies 15-17, in which the models were manually modified by adding protons
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on some ionizable residues (e.g., Asp and Glu), based on their local environments. In
other words, the models were built to mimic the structures determined at low pH and to
represent the active enzyme at low pH (i.e., not at neutral pH at which the enzyme is
inactive). The average structure from the 1.2 ns QM/MM MD simulations for the
tetrahedral adduct complex was then performed to test whether the experimental Xstructure could be well reflected from the models that we built. If the interactions in the
experimental structure could not be well represented by a model, the structure would be
expected to deviate significantly from the experimental structure during the simulations.
After several tests, we were able to generate the model for which the average structure
from the MD simulations was rather close to the experimental structure obtained at low
pH, suggesting that the interactions in the tetrahedral adduct complex are well
represented and that the model should be reasonable. For instance, the distances between
the non-hydrogen atoms for the key hydrogen bonds in the active site from the
simulations are very close to those in the experimental structure, with an average
deviation of only about 0.1 Å. We also tested other cases and noticed that we could not
reproduce the X-structures from the simulations if we used different (presumably
incorrect) protonation states for certain residues.
The initial coordinates for the enzyme were taken from the crystal structure (PDB
ID: 1SIO, resolution 1.8 Å) of kumamolisin-As complexed with the inhibitor AcIPF (Nacetyl-isoleucyl-prolyl-phenylalaninal)

9-10

. The substrate used in the present study,

GPH*FF, contains the key residues of the internally quenched fluorogenic (IQF)
substrate [NMA-MGPH*FFPK-(DNP)DRDR] used in the earlier experimental study

9-10

,
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although it is considerably smaller. One of the key questions for performing the
simulations on kumamolisin-As is how to obtain the coordinates for the substrate
(tetrahedral intermediate) in the enzyme complex. Fortunately, an X-ray structure for the
S278A mutant of pro-kumamolisin (PDB ID: 1T1E. Resolution 1.18 Å) 8 is available that
makes generating the enzyme-complex possible. This X-ray structure contains an
activation peptide/linker running through the active site cleft. The catalytic domain of the
Ser278Ala mutant of pro-kumamolisin has a virtually identical structure compared to the
active kumamolisin. Kumamolisin-As and kumamolisin share high sequence identity
(92.7%) and their structures superimpose very well. The structures of the kumamolisinAs-AcIPF complex and the catalytic domain of the S278A mutant of pro-kumamolisin
were first superposed, and the coordinates of the P3-Arg169p―P2-Pro170p―P1His171p―P1’-Phe172p―P2’-Arg173p peptide fragment from the linker were used to
generate the coordinates of the GPH*FF substrate, with P3-Arg169p replaced by Gly and
P2’-Arg173p replaced by Phe. The coordinates of kumamolisin-As and the GPH*FF
peptide were then combined to generate the putative kumamolisin-As substrate complex
used to initiate the computational studies.
The stochastic boundary MD method

28

was used for the QM(SCC-DFTB)/MM

simulations. The system was separated into a reaction zone and a reservoir region; the
reaction zone was further divided into the reaction region and the buffer region. The
reaction region was a sphere with radius R of 16 Å, and the buffer region had R equal to
16 Å ≤ R ≤ 18 Å. The reference center for partitioning the system was chosen to be the
carbonyl carbon atom (C) of the His residue at the P1 site (see Figure VI-1). The side
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chains of Glu32, Asp82, Glu78, Ser278, and Asp164, as well as a part of the substrate
[the backbone atoms of P2-Pro (C=O), P1-His, P1’-Phe (Cα-NH) and the sidechain of P1His] were treated by QM and the rest of the system by MM. The all-hydrogen potential
function (PARAM22) 29 was used for MM atoms. The link-atom approach 30 available in
24

was used to separate the QM and MM regions. A modified

31, 32

was employed for the solvent, and explicit water spheres

the CHARMM program
TIP3P water model

covering the whole region of interest were used to solvate the system using the standard
procedure in the CHARMM program. The resulting system contains 3431 atoms (2630
enzyme atoms and 267 water molecules, including 79 crystal water molecules). The
initial structure for the entire stochastic boundary system was optimized by adopted basis
Newton-Raphson (ABNR) method. The system was gradually heated from 50 to 310 K in
20 ps and equilibrated at 300 K for 80 ps. A 1-fs time step was used for integration of the
equations of motion, and coordinates were saved every 10 fs for analyses. The LD
frictional constants were 250 ps-1 for the protein atoms and 62 ps-1 for the water
molecules. The bonds involving hydrogen atoms in the MM region were fixed by the
SHAKE algorithm (33). 500 ps QM/MM MD simulations were performed for the
substrate, tetrahedral intermediate and acyl-enzyme complexes of the wild-type enzyme;
the initial structures of the tetrahedral intermediate and acyl-enzyme complexes were
obtained from the free energy simulations (see below). The fluctuations of some
important distances related to the proton motions were monitored with the coordinates
obtained from the trajectories of the 500 ps simulations.
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implemented in the CHARMM program and

Weighted Histogram Analysis method (WHAM) 35 were applied to determine the change
of the free energy (PMF) for the acylation reaction in wild-type. The reaction coordinate
[ξ = R(C-N) – R(C…Oγ)] used in the study is the difference between the bond distance of
the scissile peptide bond [R(C-N)] and the R[Oγ(Ser278)…C] distance of the nucleophilic
attack (see Figure VI-1A), the two key distances for the change of the substrate to the
acyl-enzyme. The determination of multi-dimensional free energy maps involving all the
coordinates would be too time-consuming. Our previous study

17

indicated that the one-

dimensional free energy simulations with the suitable reaction coordinate would be
sufficient to determine the key energetic properties for the reaction. The free energy
profile for the wild-type enzyme, with the proton fixed on Asp164 using the SHAKE
algorithm 30, was also obtained. 18-22 windows along the reaction coordinate were used
between the substrate complex and acyl-enzyme. The force constants that were used are
in the range of 100-800 kcal·Mol-1·Å-2.

Similar free energy profiles and the same

conclusions were obtained from three different sets of PMF calculations with the MD
simulations ranging from 40 ps (20 ps equilibration and 20 ps production run) to 100 ps
(50 ps equilibration and 50 ps production run) for each window.
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Results and Discussion
Structural and dynamic properties of the substrate complex, tetrahedral
intermediate, and acyl-enzyme
The average active-site structure for the kumamolisin-As-substrate (GPH*FF)
complex obtained from the QM/MM MD simulations is given in Figure VI-1A. Ser278 is
the nucleophile that attacks the carbonyl carbon atom (C) of the substrate, while Glu78
and Asp164 act as the general base and acid catalysts, respectively

4-10, 15-17

. Two

additional residues, Glu32 and Trp129, interact with Asp82 of the catalytic triad through
hydrogen bonding networks. These two residues may play an important role in
maintaining the structural integrity of the active site. Indeed, the previous experimental
study (8) on kumamolisin showed that Glu32→Ala and Trp129→Ala mutations affect
the active-site conformation, leading to a 95% decrease in the activity. The backbone NH group and sidechain of Thr277 interact with Asp164, and it was suggested in the earlier
computational study

15

that these interactions might play a role in stabilizing negative

charge formation on Asp164 during the nucleophilic attack. The motions of the three
protons that may be important for catalysis (i.e., those between Asp164 and substrate,
Ser278 and Glu78, and Glu78 and Asp82) are monitored from the trajectories of the MD
simulations of the substrate complex and are plotted in Figure VI-1B. Figure VI-1B
shows that, for the substrate complex, these protons are located on Asp164, Ser278 and
Asp82, respectively, consistent with the average structure shown in Figure VI-1A. The
fluctuation of the H-O(D82) distance is larger than that for a normal H-O bond [e.g.,
comparing the fluctuations with those of H-O(D164) and H-O(S278)], indicating that the
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corresponding H-O(D82) covalent bond is weakened as a result of the strong hydrogen
bonding interaction with Glu78 (the distance of the hydrogen bond between Glu78 and
Asp82 is only 1.5 Å).
The average structure for the tetrahedral intermediate obtained from the
simulations is shown in Figure VI-1C. In this structure, the Ser278 residue has already
attacked the substrate and transferred its proton to Glu78. The proton on Asp164 has
transferred to the substrate during the formation of the tetrahedral intermediate. Thus,
Glu78 and Asp164 played the roles of the general base and acid catalysts, respectively,
during the nucleophilic attack. Preventing the proton transfer from Asp164 to the
substrate increases the free energy for the formation of the tetrahedral intermediate
significantly (see below), highlighting the importance of the role of Asp164 as the
general acid catalyst. A similar discussion can be made for Glu78

17

. It is of interest to

note from Figure VI-1D (bottom panel) that the H-O(D82) bond does not undergo the
large fluctuations (as observed in the substrate complex) in the tetrahedral intermediate;
the corresponding H-bond distance to Glu78 is also longer (~1.9 Å). The average
structure of the acyl-enzyme is given in Figure VI-1E, and the fluctuations of the
distances related to the proton motions are plotted in Figure VI-1F. Figures VI-1E and
VI-1F show that Glu78 has given up its proton to the nitrogen atom (N) of Phe at P1’,
leading to the breaking of the C-N peptide bond between P1-His and P1’-Phe and the
formation of the acyl-enzyme. Asp164 becomes protonated again and therefore acted as a
general base during the acyl-enzyme formation. It is interesting to note that a low-barrier
hydrogen bond is formed between Glu78 and Asp82 in the acyl-enzyme (Figure VI-1F,
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bottom panel); the proton is almost equally distributed on Glu78 and Asp82 during the
MD simulations.

Free energy profiles of the acylation
The changes of free energy (potential of mean force) as functions of the reaction
coordinate (ξ) for the acylation reaction in kumamolisin-As and D164A mutant are given
in Figure VI-2A. The free energy change in which the proton on Asp164 is fixed by the
SHAKE algorithm

30

(to prevent Asp164 acting as the general acid and base catalyst for

the nucleophilic attack and acyl-enzyme formation, respectively) is also given. It should
be pointed out the free energy profiles in Figure VI-2A were based on the onedimensional free-energy simulations. For the step-wise bond breaking and making events
this may not pose a serious problem. However, for the concerted processes some
information that would be contained in multi-dimensional free-energy profiles may be
absent in the one-dimensional profiles. Indeed, there are several proton transfers during
the acylation reaction, and some of these proton transfers may be coupled to the
rearrangement of the system (i.e., the nucleophilic attack and the formation of the acylenzyme). For instance, our earlier two-dimensional free energy simulations on the
nucleophilic attack of Ser-278 on AcIPF in kumamolisin-As showed that there are
important free-energy relationships between the nucleophilic attack and the proton
transfers. Such free energy relationships between the nucleophilic attack (acyl-enzyme
formation) and proton transfers are absent in the one-dimensional free energy profiles
(Figure VI-2A). However, the previous study

17

also indicates that one-dimensional free
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energy simulations with the suitable reaction coordinate should be sufficient to determine
the key energetic properties for the acylation reaction.
Figure VI-2A shows that the nucleophilic attack by the serine residue on the
substrate is not rate limiting for the acylation reaction, although the free energy barriers
for the nucleophilic attack (TS1) and formation of the acyl-enzyme (TS2) do not differ
significantly, with the barrier at TS2 slightly higher. The result obtained for
kumamolisin-As is different from the previous calculations on trypsin 20 which suggested
that the nucleophilic attack is rate limiting for the acylation in the serine peptidase. It is of
interest to note in Figure VI-2A that preventing the proton transfer away from Asp164
leads to an increase of the free energy barrier of the acylation reaction by about 10
kcal/mol and the tetrahedral intermediate along the reaction pathway disappeared as a
result of fixing the proton on Asp164. Thus, the electrostatic oxyanion-hole interaction
involving the protonated Asp164 is unlikely to be sufficient for generating a stable
tetrahedral intermediate during catalysis. Figure VI-2A also shows that the replacement
of Asp164 by Ala increases the free energy barrier considerably. The results of the
simulations reported here support the earlier proposal

15

for the existence of the general-

acid mechanism involving Asp164 in the stabilization of the tetrahedral intermediate and
are consistent with the available mutagenesis studies 7-10. For instance, the D164A mutant
of kumamolisin did not show any measurable proteolytic activity 7. For the D164N
mutant of kumamolisin-As, a low but appreciable level of catalytic activity (1.3%) was
found

10

, corresponding to an increase of the activation barrier of about 2.5 kcal/mol. It

should be pointed out, however, that care must be exercised in making direct
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comparisons of the computational results with experimental data. For instance, the
acylation reaction has not been proven to be rate-limiting and the processes of the
deacylation, substrate binding, and product release may need to be considered as well.
Furthermore, structural analyses of the unliganded D164N mutant showed that, although
the catalytic triad is intact, the mutated residue (Asn164) unexpectedly makes a hydrogen
bond with the side chain of Ser278 10. The consequence of this structural change and the
way by which the side chain of Asn164 stabilizes the transition state in the reaction
catalyzed by the D164N mutant are still unknown.
The average active-site structures near the transition states for the nucleophilic
attack (TS1) and the formation of the acyl-enzyme (TS2) are given in Figure VI-2B.
Figure VI-2B (left) shows that there is little progress of the proton transfer from Asp164
to the substrate before the system reaches TS1. The result is consistent with the earlier
suggestion that such proton transfer mainly occurs at a later stage of the nucleophilic
attack

15, 17

. The proton transfer from Ser278 to Glu78 seems to be more synchronous

with the nucleophilic attack, although two-dimensional free energy maps are required for
a detailed understanding of the relationship between the nucleophilic attack and proton
transfer 17. Figure VI-2B (right) shows that the proton transfer from Glu78 to the nitrogen
atom (N) of Phe at P1’ has been basically completed at TS2.

Dynamic substrate assisted catalysis (DSAC)
Kumamolisin-As was found to have a higher specificity for the substrates with a
positively charged residue (such as His or Arg) at the P1 site than for those they do not 2, 3,
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. Interestingly, the linkers of pro-kumamolisin-As and pro-kumamolisin (-P3-

Arg169p―P2-Pro170p―P1-His171p―P1’-Phe172p―P2’-Arg173p-)
positively charged His residue at P1

7-10

also

have

a

; the coordinates of this peptide fragment from

pro-kumamolisin have been used to generate the substrate complex used in this study (see
above). It was found in our earlier simulations

16

that the His sidechain at P1 rotated

significantly during transition from the substrate to the tetrahedral intermediate. This
movement was triggered by the deprotonation/protonation events and resulted in the
interaction of His at P1 with the unprotonated Asp164 making the tetrahedral intermediate
more stable. We suggested that the dynamics involving the His residue at the P1 site may
play an important role in the catalysis and contribute to the higher specificity for the
substrates with His at P1. These results are confirmed here with a different substrate.
Indeed, while His at P1 forms a hydrogen bond with the C=O’ group of Pro at P2 in the
substrate complex (Figure VI-1A), it interacts with Asp164 in the tetrahedral intermediate
(Figure VI-1C).
The previous proposal for the existence of DSAC in the kumamolisin-Ascatalyzed reaction was based on the results of the nucleophilic attack by Ser278 on a
substrate. However, as demonstrated earlier, the nucleophilic attack may not be the rate
limiting step for the acylation. Thus, a question remains as to whether the His residue at
P1 would be able to stabilize the transition state for the acyl-enzyme formation (TS2) as
well, and therefore lead to an overall rate enhancement for the acylation reaction. The
structure shown in Figure VI-1E suggests that this may be indeed the case, as His at P1
moves back to its original position (i.e., to that found in the substrate complex) to interact
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with the C=O’ group of Pro at P2 in the acyl-enzyme. Figure VI-2B (right) shows that the
motion of the His residue from the position in the tetrahedral intermediate to that in the
acyl-enzyme is almost completed as the system reaches TS2, the transition state for the
acyl-enzyme formation. This is in contrast to the case of the TI formation, where His at
P1 undergoes the conformational change mainly after the system passes TS1 (see above).
Figure VI-3 shows a plot of the free energy profiles for His at P1 moving between
the C=O’ group of Pro at P2 and Oδ2 of Asp164 in the substrate complex, tetrahedral
intermediate, and acyl-enzyme; the distance between the Hδ1 hydrogen atom of the His
sidechain (i.e., H indicated in Figures VI-1A, VI-1C and VI-1E) and Oδ2 of Asp164 is
used as the reaction coordinate (RC). For the substrate complex, the free energy for the
conformations for which the His residue forms a hydrogen bond with the C=O’ group
(RC ~ 4.2Å) is considerably lower than the free energy of those with the
Oδ2(Asp164)…H(His) hydrogen bond; the conformations in the former case are therefore
more stable. This result is consistent with the average structure shown in Figure VI-1A
where the His residue interacts with C=O’. For the TI complex, the conformations with
the Oδ2(Asp164)…H(His) hydrogen bond become more stable, as indicated by the
relatively

low

free

energy

at

RC=1.7Å.

The

conformations

with

the

Oδ2(Asp164)…H(His) hydrogen bond become less stable again after the system changes
to the acyl-enzyme. Therefore, the His residue at P1 moves between the C=O’ group of
Pro at P2 and Oδ2 of Asp164. Each movement is triggered by the bond breaking and
making events at a given stage of the reaction, as well as the corresponding changes of
the interactions with the His residue. The back and forth movements of the His sidechain
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between the C=O’ group of Pro at P2 and Oδ2 of Asp164 in a ping-pong-like mechanism
and the formation of the alternative hydrogen bonds effectively lower the free energy
barriers for the both nucleophilic attack and the acyl-enzyme formation. It is possible that
this mechanism also works for the deacylation reaction. In other words, the water attack
on the acyl-enzyme and the formation of the product might also be helped by the motions
of the His residue in the same ways as what happened for the nucleophilic attack by
Ser278 and the formation of the acyl-enzyme, respectively.

Conclusions
The QM/MM MD and free energy simulations demonstrated that the nucleophilic
attack by the serine residue on the substrate may not be the rate limiting step for the
acylation of the GPH*FF substrate. The results given here confirm the earlier suggestions
that Asp164 acts as a general acid during the nucleophilic attack by Ser278. It was also
shown that this residue acts as a general base during the formation of the acyl-enzyme
from the tetrahedral intermediate. The role of dynamic substrate assisted catalysis
(DSAC) involving His at the P1 site was examined, and it was shown that the bond
breaking and making events at each stage of the reaction trigger a change of the position
for the His sidechain and lead to the formation of alternative hydrogen bonds. The back
and forth movements of the His sidechain between the C=O’ group of Pro at P2 and Oδ2
Asp164 and the formation of the corresponding hydrogen bonds effectively lower the free
energy barriers for the both nucleophilic attack and the acyl-enzyme formation and leads
to a relatively high activity.
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Appendix

Figure VI-1. The average active-site structures of the kumamolsin-As-substrate
(GPH*FF) complex, tetrahedral intermediate and acyl-enzyme obtained from the
simulations, and the motions of the three key protons involved in the catalysis.
The initial structures of the simulations for the tetrahedral intermediate and acyl-enzyme were based on the
structures from the free energy simulations (see below). (A) The average structure of the substrate complex.
The enzyme is plotted in ball and stick and the substrate in stick. Hydrogen bonds (H-bonds) are indicated
by red dashed lines. Only the sidechain of the P1 (His) residue of the substrate is shown for clarity. The
catalytic triad contains the Ser278, Glu78 and Asp82 residues. The His side chain at P1 donates an H-bond
to the C=O’ group of Pro at P2, in addition to the carboxylate of Asp179 (not shown). The backbone N-H
group of the P1 residue donates a hydrogen bond to Glu78. (B) Fluctuations of the distances (in Å) related
to proton motions (vibrations) between Asp164 and substrate, Ser278 and Glu78, and Glu78 and Asp82 in
the substrate complex. Top panel: fluctuations of the H-O(D164) and H…O(substrate) distances as function
of time. Red, R[H…O(substrate)]; blue, R[H-O(D164)]. The proton is on Asp164 and is involved in an Hbond with the C=O group of the substrate (see also Figure VI-1A). Middle panel: the fluctuations of the HO(S278) and H…O(E78) distances as function of time. Red, R[H…O(E78)]; blue, R[H-O(S278)]. The
proton is on Ser278 and is involved in an H-bond with Glu78. Bottom panel: the fluctuations of the
H…O(E78) and H-O(D82) distances as function of time. Red, R[H-O(D82)]; blue, R[H…O(E78)]. The Hbond formed between Glu78 and Asp82 has a short distance of ~1.5 Å, and the proton is mainly located on
Asp82. (C) The average structure of the tetrahedral intermediate after the nucleophilic attack by Ser278 on
the substrate. The His sidechain at P1 now interacts with Oδ2 of Asp164 and may, therefore, play a role in
stabilizing the charge formation on Asp164. The H-bond between the backbone N-H group of the P1
residue and Glu78 becomes significantly weaker due to the protonation of Glu78. (D) Fluctuations of the
distances related to proton motions (vibrations) in the tetrahedral intermediate complex. Top panel: the
fluctuations of the H…O(D164) and H-O(tetrahedral intermediate) distances as functions of time. Red,
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R[H-O(tetrahedral intermediate)]; blue, R[H…O(D164)]. The proton is on the tetrahedral intermediate and
is involved in an H-bond with Asp164 (see Figure VI-1C).

Middle panel: the fluctuations of the

H…O(S278) and H-O(E78) distances as function of time. Red, R[H-O(E78)]; blue, R[H…O(S278)]. The
proton is on Glu78 and is involved in an H-bond with Ser278. Bottom panel: the fluctuations of the
H…O(E78) and H-O(D82) distances as function of time. Red, R[H-O(D82)]; blue, R[H…O(E78)]. (E) The
average structure of the acyl-enzyme with the C-N bond broken. (F) Fluctuations of the distances related to
proton motions (vibrations) in the acy-enzyme. Top panel: the fluctuations of the H-O(D164) and H…O
distances as function of time. Red, R[H…O]; blue, R[H-O(D164)]. Middle panel: the fluctuations of the
H…O(S278) and H…O(E78) distances as function of time. Red, R[H…O(E78)]; blue, R[H…O(S278)].
Bottom panel: the fluctuations of the H…O(E78) and H…O(D82) distances as function of time. Red,
R[H…O(D82)]; blue, R[H…O(E78)].

Figure VI-1, continued.
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Figure VI-2. The free energy profiles of the acylation and the average structures at
the transition states for the nucleophilic attack and the formation of the acyl-enzyme
(A) The free energy profiles of the acylation reaction for the wild-type kumamolisin-As and D164A mutant
as a function of the reaction coordinate [ξ = R(C-N) – R(C…Oγ)] obtained from the QM/MM free energy
(potential of mean force) simulations. Red solid line: wild-type; blue dot-dashed line: wild-type with the
proton fixed on Asp164 with the SHAKE algorithm; pink dashed line: D164A mutant. The average
structures for the substrate complex, tetrahedral intermediate and acyl-enzyme for wild-type are given in
Figure VI-1A, VI-1C and VI-1E, respectively. (B) The average active-site structures for wild-type near the
transition states for the nucleophilic attack (TS1) and the formation of the acyl-enzyme (TS2), respectively,
obtained from the free energy simulations.
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Figure VI-3. The free energy changes for the shifts of P1 His side chain
The free energy change as the side chain of His residue at P1 moves between Oδ2 of Asp164 and O’ of the
C=O’ group of Pro at P2 in the substrate complex, tetrahedral intermediate and acyl-enzyme of
kumamolisin-As (see Figures VI-1A, VI-1C and VI-1E for average structures). The reaction coordinate is
the distance between the hydrogen atom (H) of the His residue at P1 and Oδ2 of Asp164. The corresponding
average distances between H and O’ are given below. For instance, when the reaction coordinate is 4.2 Å
for the substrate complex, the average distance for r(H…O’) is about 1.8 Å based on the trajectory of the
corresponding window (i.e., H forms a hydrogen bond with the C=O’ group of Pro at P2). Blue dotted line:
the free energy change in the substrate complex. For the substrate complex, the conformations for which
His at P1 forms a hydrogen bond with the C=O’ group of Pro at P2 (i.e., the structure shown in Figure VI1A) are considerable more stable (by about 5-6 kcal/mol) than the conformations for which the His residue
interacts with Oδ2 of Asp164. Black solid line: the free energy change in the tetrahedral intermediate. For
the tetrahedral intermediate, the conformations for which the His at P1 forms a hydrogen bond with Oδ2 of
Asp164 (i.e., the structure shown in Figure VI-1C) are more stable (by about 2 kcal/mol) than the
conformations for which His interacts with C=O group of Pro at P2. Red dashed line: the free energy
change in the acyl-enzyme. The conformations for which the His residue forms a hydrogen bond with the
C=O’ group of Pro at P2 (i.e., the structure shown in Figure VI-1E) are considerable more stable than the
conformations for which His at P1 interacts with Oδ2 of Asp164.
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ABSTRACT
Histone lysine methylation catalyzed by protein lysine methyltransferases
(PKMTs) can govern many important biological processes, including heterochromatin
formation, X-chromosome inactivation, and transcriptional silencing and activation.
Biological consequences of histone lysine methylation may differ depending on whether
the lysine residue is mono-, di- or tri-methylated. Therefore, the ability of different
PKMTs to generate different methylation states for the lysine residue, which is termed as
product specificity, adds more complexity to the histone code and provides an additional
layer of regulatory control. Understanding the origin of the product specificity and
developing suitable computational models for its prediction are of fundamental
importance. Here quantum mechanical/molecular mechanical (QM/MM) molecular
dynamics (MD) simulations are performed on the reactant complexes for the 1st, 2nd and
3rd methyl transfers from AdoMet to the target lysine/methyl lysine in the N. crassa DIM5 (a trimethylase) and human SET7/9 as well as their mutants to establish the correlation
between the formation of the reactive configurations for the methyl transfers and product
specificity. In addition, the free energy profiles for the methyl transfer processes are
determined. The results provide important insights into the origin of product specificity
for PKMTs. Moreover, they support a hypothesis that the triplet code consisting of the
difference in free energy barriers for the three methyl transfers can be used as important
parameters in the determination of how the epigenetic marks of lysine methylation are
written by the enzymes. Other important results from the simulations are also reported
and discussed.
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Introduction
The nucleosome is the fundamental building block of eukaryotic chromatin, and
histone proteins play an important role in packaging DNA into nucleosome.1 The tails of
the histone proteins are subject to a variety of post-translational covalent modifications.
These modifications form the so-called epigenetic histone code read by other proteins,
which leads to distinct downstream events in the regulation of chromatin structure and
gene expression.2 One such modification is histone lysine methylation catalyzed by
protein lysine methyltransferases (PKMTs).3 Previous studies have shown that histone
lysine methylation can govern many important biological processes, including
heterochromatin formation, X-chromosome inactivation, and transcriptional silencing and
activation. (For reviews, see Ref. 4) Several lysine residues on histone proteins have
been identified to be the sites of methylation, including histone H3 Lys-4 (or simply H3K4), H3-K9, H3-K27, H3-K36, H3-K79 and H4-K20. The methylated lysine residues can
then serve as the docking sites for methyl-lysine binding domains and effector proteins to
mediate the downstream events in the regulation of chromatin structure and gene
expression.4 There are two known enzyme families involved in the lysine methylation,
the SET (Su(var)3-9, Enhancer-of-zeste, Trithorax) domain proteins and Dot1p, and these
two families have entirely different structural scaffolding. A number of crystal structures
for the complexes of the SET domain PKMTs (including SET7/9, SET8, Clr4, DIM-5,
vSET and pLSMT) have been determined.5-6 These structures showed that substrate and
AdoMet are located on the opposite surfaces, with the target lysine side chain accessing
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the active site and the cofactor through a narrow channel. The crystal structures for the
non-SET domain enzymes, yeast Dot1p and human Dot1L, have also been determined.7
In addition to the differences in their selection of the sites for methylation
(substrate specificity), PKMTs may also differ in their ability to transfer one, two or three
methyl groups from S-adenosyl-L-methionine (AdoMet) molecule(s) to the ε-amino
group of the target lysine. This is because lysine residue has three protons, and each of
them may be replaced by a methyl group (Figure VII-1A). For instance, DIM-5 of N.
crassa (to be studied in this paper) generates primarily trimethyl H3 Lys-9, which marks
chromatin regions for DNA methylation.6 Another PKMT, which has been a subject of
previous computational investigations,8-10 is human SET7/9 that generates exclusively
mono-methyl H3 Lys-4. The ability of different PKMTs to direct different degrees of
methylation is called product specificity, and the enzymes can therefore be classified as
mono-methylases, di-methylases or tri-methylases. For the SET domain di-methylases
and tri-methylases, the methylation processes are believed to proceed processively
without the release of the intermediates from the active sites (Figure VII-1B).6b,

14

Biological consequences of histone lysine methylation may be quite different depending
on whether the lysine residue is mono-, di- or tri-methylated. Therefore, the product
specificity adds more complexity to the histone code and provides an additional layer of
regulatory control. Thus, determination of the origin of the product specificity and
development of suitable computational models/techniques for its prediction are of
fundamental importance. This type of research may help to develop strategies for
manipulating signal properties and turning epigenetic mechanisms of gene regulation into
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tools of therapeutic intervention in diseases. Nevertheless, our understanding of the
factors that control the product specificity is still lacking.
Structural analyses of the SET-domain PKMT complexes led to the suggestion
that the geometry and shape at the bottom of the lysine access channel might be one of
the key factors for controlling the product specificity for these enzymes (for reviews, see
Ref. 11). For instance, the crystal structure5b of SET7/9 complexed with S-adenosyl-Lhomocysteine (AdoHcy) and a histone H3 methyl-lysine-4 (H3-K4me) peptide showed
that the rotation around the C-N bond of the methyl-lysine side chain could be prohibited
at the active site,5b, 11d making the formation of the reactive configuration for addition of
the second methyl group more difficult. This suggestion is consistent with the fact that
SET7/9 is a mono-methylase.5-6 Additional experimental studies were performed to
pinpoint the active-site amino acid residue(s) that are responsible for product specificity.
It should be pointed out that the key question for understanding product specificity is why
for mono-methylases only one methyl group can be added to the target lysine, while for
tri-methylases (di-methylases) multiple methyl additions can be achieved. In other words,
the main focus is to identify the residue(s) and factors that control the methylation state
of the product. This question is different from the question of identifying the residues and
factors that are crucial for the general catalysis (i.e., regardless whether it is monomethylation, di-methylation or tri-methylation). One proposal that is of considerable
interest is the existence of a tyrosine/phenylalanine switch that controls the product
specificity for some of the SET-domain PKMTs. Comparison of the active sites of
SET7/9 and DIM-5 showed that a single amino acid residue occupies a structurally
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similar position in both enzymes (F281 of DIM-5 and Y305 of SET7/9) and is in
proximity of the ε-amino group of the target lysine.6b It was hypothesized that the Y305
hydroxyl in SET7/9 might be the source of steric hindrance that limits the further
methylation by the enzyme.6b This hypothesis has been supported by the experimental
studies. Indeed, it was shown that DIM-5 could be converted from a K-9 tri-methylase to
a K-9 mono/di-methylase by the F281Y mutation, while the SET7/9 Y305F mutant
generated dimethylated instead of monomethylated K-4.6b In each case, the substrate
specificity (K-9 vs. K-4) and the overall reaction rate were not changed as a result of the
mutation. The further supports for the existence of the tyrosine/phenylalanine switch for
product specificity came from the studies on human SET8 (a histone H4-K20 monomethylase) 5e and G9a (a predominant H3-K9 PKMT that directs euchromatic mono- and
di-methylation).6e Although previous structural studies have provided considerable
insights, there remain many questions that need to be addressed in order to understand the
origin of the product specificity. For instance, the role of the steric hindrance at the
bottom of the lysine access channel in controlling product specificity has been called into
question recently.9b Hu et al.9b argued that since the methyl group is very small and
protein structures are very dynamic, there is a question as to how the steric hindrance
could be imposed (see below for further discussions). Nevertheless, the functions of
many enzymes depend on their remarkable sensitivity to subtle changes in the structures
of the target molecules and reaction transition states,12 and these powers of binding
discrimination are a result of the combination and balance of different interactions in the
enzyme complexes.13 This is probably true for the product specificity as well, but an
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intriguing question is exactly how the existence and absence of a single hydroxyl group
on one residue can lead to such large effects on the reaction product.
Molecular dynamics (MD) simulations have been applied to study structural and
energetic consequences of different interactions in the enzyme complexes and to
understand the origin of product specificity. One approach that has been used for PKMTs
8-9

is to examine the reactant complexes prior to each of the methyl transfers and

determine the relationship between the product specificity and the populations of the
reactive configurations from which the methyl transfers would occur efficiently. Since
the lone pair of electrons on Nζ of the target lysine/methyl lysine is the site for the methyl
addition, the structures with good alignments of the methyl group of AdoMet with the
electron lone pair on Nξ are expected to lead to an efficient methyl addition (see Figure
VII-1C), whereas the structures with poor alignments would make the methyl transfer
less likely, leading to the potential termination of the methylation process. The previous
simulations8-9 have showed that while there was a large population of the reactive
structures with relatively short r(CM…Nζ) distances (~2.9 Å) and small θ angles (close to
0°) for the first methyl transfer in wild-type SET7/9, the population of such well-aligned
reactive structures became very small for the second methyl transfer. The results from the
simulations are therefore consistent with the fact that SET7/9 is a mono-methylase and
can

only

catalyze

the

first

methyl

addition

to

H3-K4.

Interestingly,

the

tyrosine/phenylalanine switch hypothesis proposed earlier was also confirmed from the
simulations on SET7/9 and its Y305F mutant.8 Indeed, it was shown8 that the active site
of Y305F was able to adopt the reactive structures with short r(CM…Nζ) distances and
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small θ angles both for the first and second methyl transfers, consistent with the
experimental observation that Y305F is a di-methylase.6b Although there is a good
correlation between the formation of reactive configurations and product specificity,
there may exist different interpretations. Hu et al.9b argued recently that the main
controlling factor for the lacking of di-methylation activity for SET7/9 was not the steric
hindrance which resulted in the disruption of the formation of the reactive conformation.
They showed that the lone pair of electrons on Nξ of the methyl lysine formed an
Nξ···H−O hydrogen bond in the reactant complex for the 2nd methyl transfer from the MD
simulations, which was connected with solvent water molecules on the protein surface
through a water chain. It was argued that extra energy would be required to break this
hydrogen bond and to push a water molecule out of the water channel during the 2nd
methyl transfer in SET7/9 and that it was this energetic cost that made SET7/9 a monomethylase.9b Additional simulations on other PKMT systems are still necessary to
confirm this proposal.
Although understanding the connection between the structural properties of the
reactant complexes and product specificity is of importance, determining the energetic
properties for the methyl transfers, including the activation barriers at the transition
states, may provide some key insights into the origin of product specificity. Such
energetic information can be obtained through the use of quantum mechanical/molecular
mechanical (QM/MM) free energy (potential of mean force) simulations. Since the main
focus is to understand and predict the methylation states of the products generated by
different PKMTs (see above), it is important to establish the relationship between the
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relative activation barriers for different methyl transfer processes with the product
specificity. In our earlier study,8 it was demonstrated that for wild-type SET7/9 the freeenergy barrier for the 2nd methyl transfer from AdoMet to H3-K4me was 5 kcal/mol
higher than that of the 1st methyl transfer from AdoMet to H3-K4. The higher free-energy
barrier for the 2nd methyl transfer means that the dimethylation would be a much slower
process and the product of mono-methylation would presumably be released before the
second methyl could be added. The results of the simulations therefore agreed with the
findings that SET7/9 is a mono-methylase. For Y305F, the free-energy simulations
demonstrated that, unlike wild type (WT), the both free-energy barriers for the 1st and 2nd
methyl transfers were rather low, consistent with the experimental observations that
Y305F is a dimethylase and supporting the tyrosine/phenylalanine switch hypothesis.6b
In addition to the interpretations of the product specificity based on the methyl
transfer processes (including those based on the populations of the reactive
configurations and the free energy profiles for the methyl transfers mentioned above),
Zhang and Bruice10 suggested that the product specificity was controlled by the process
of the deprotonation of the positively charged methyl lysine generated from the earlier
methylation step (see Figure VII-1B). This deprotonation is absolutely required, because
the basic form of the methyl lysine is the nucleophile and the lone pair of electrons on its
Nζ is the site where an additional methyl group can be added. They proposed that only
water molecules in water channels observed from their MD simulations could play the
role in the deprotonation, and the formation of the water channel therefore had to precede
each of the next methyl additions.10

Thus, for mono-methylases (di-methylaes) the
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failure to form a water channel required for the deprotonation of Lys-Nζ(Me)H2+ (LysNζ(Me)2H+) was believed to prevent further methylation by the enzymes, leading to the
mono-methyl (di-methyl) lysine product.10 One of the key assumptions in this proposal is
that for the reactions catalyzed by tri-methylases the PKMT·Lys-Nζ(Me)H2+·AdoMet and
PKMT·Lys-Nζ(Me)2H+·AdoMet complexes must be formed during the processive
methylation processes; for di-methylases PKMT·Lys-Nζ(Me)H2+·AdoMet must be
formed. Indeed, the results of the simulations by Zhang and Bruice10 showed that the
water channels that were observed in PKMT·Lys-Nζ(Me)H2+·AdoMet and PKMT·LysNζ(Me)2H+·AdoMet could not form in PKMT·Lys-Nζ(Me)H2+·AdoHcy, PKMT·LysNζ(Me)2H+·AdoHcy, PKMT·Lys-Nζ(Me)H2+ or PKMT·Lys-Nζ(Me)2H+. Nevertheless, to
the best of our knowledge there is no experimental evidence to support the formation of
PKMT·Lys-Nζ(Me)H2+·AdoMet

and

PKMT·Lys-Nζ(Me)2H+·AdoMet

during

the

methylation processes, and previous studies8,14 proposed that the deprotonation of methyl
lysine might actually occur after dissociation of AdoHcy and before binding of the next
AdoMet molecule (i.e., starting from PKMT·Lys-Nζ(Me)H2+ or PKMT·Lys-Nζ(Me)2H+).
Moreover, one would expect potential strong repulsions between the two positively
charged groups, AdoMet and Lys-Nζ(Me)2H+ (AdoMet and Lys-Nζ(Me)H2+), in the
PKMT·Lys-Nζ(Me)2H+·AdoMet (PKMT·Lys-Nζ(Me)H2+·AdoMet) complex. Therefore,
additional experimental and computational work is necessary to determine whether the
PKMT·Lys-Nζ(Me)H2+·AdoMet and PKMT·Lys-Nζ(Me)2H+·AdoMet complexes exist or
not. Furthermore, there seem to be other inconsistencies in this proposal. For instance, the
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while previous

experimental data showed that Y245F is a weak mono-methylase.5b
In this article, the results of quantum mechanical/molecular mechanical
(QM/MM) molecular dynamics (MD) and free energy simulations are reported for DIM5; some unpublished data for SET7/9 are given as well. DIM-5 from N. crassa is a
SUV39-type H3K9 tri-methylase that is essential for DNA methylation in vivo. The
existence of a large body of experimental data6 for the wild type and mutated DIM-5
allows us to test a variety of proposals through computational investigations. To the best
of our knowledge, this is the first time that the simulation results are reported for DIM-5.
Our results on DIM-5 suggest that the triplet code consisting of the difference in free
energy barriers for the three methyl transfers from AdoMet to the target lysine/methyl
lysine may determine how the epigenetic marks of lysine methylation are written by the
enzyme. The origin for the existence of the tyrosine/phenylalanine switch is discussed,
and detailed interpretations are also provided.

Methods
Quantum mechanical/molecular mechanical (QM/MM) free energy (potential of
mean force) simulations were applied to the studies of the 1st, 2nd and 3rd methyl transfers
catalyzed by wild type DIM-5, F281Y mutant of DIM-5, wild type SET7/9 and Y305F
mutant of SET7/9, using the CHARMM program15. AdoMet/AdoHcy and lysine/methyllysine side chains of the substrates and products were treated by QM and the rest of the
system by MM. The link-atom approach18 available in the CHARMM program was
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applied to covalent bonds on the boundary of the QM and MM regions. The SCCDFTB16 method was used for the QM description in the present study; high level ab initio
methods (e.g., B3LYP and MP2) are too time-consuming to be used for MD and free
energy simulations. Based-on an iterative energy minimization by adopted basis NewtonRaphson (ABNR) and the reaction coordinate driving approach,9d the energetic profiles
using the SCC-DFTB and B3LYP/6-31G** methods for the description of the methyl
transfer in a small model system were first compared.8 Such comparisons are necessary
and allow us to understand the performance of the semi-empirical method for the systems
under investigations. (See Ref. 8 for additional discussions.)
The all-hydrogen potential function (PARAM22)17 was used for the MM atoms.
A modified TIP3P water model19 was employed for the solvent. The stochastic boundary
molecular dynamics method20 was used for the QM/MM MD and free energy
simulations. The system was separated into a reaction zone and a reservoir region; the
reaction zone was further divided into the reaction region and buffer region. The reaction
region was a sphere with radius r of 22 Å, and the buffer region had r equal to 20 Å ≤ r ≤
22 Å. The reference center for partitioning the system was chosen to be the Cδ atom of the
target lysine residue, Lys9 of the histone H3 peptide or the methylated Lys9. The
resulting systems contain around 5500 atoms, including about 800-900 water molecules.
The initial coordinates for the reactant complexes of the 1st, 2nd and 3rd methyl
transfers were mainly based on the crystallographic dimmer complex (PDB code: 1PEG)
of DIM-5 containing AdoHcy and a short H3K9 peptide.6b For the mono-methylation, a
methyl group was manually added to AdoHcy to change it into AdoMet. By comparing
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with the structure of SET7/9 (PDB code: 1O9S)5b and LSMT (pea Rubisco large subunit
methyltransferase, PDB code: 1OZV)5h, a crystal water was docked to the active site
based on the X-ray structure of SET7/95b with superposition and further optimization
using MOE.24 This procedure led to the reactant complex for mono-methylation
containing DIM-5, AdoMet and the H3-K9 peptide. For the study of the second methyl
transfer from AdoMet to the mono-methylated Lys-9 (H3-K9me), one methyl group was
manually added to AdoHcy to change it into AdoMet and one to H3K9 peptide (based on
the X-ray structure of SET7/9 that contains a methyl-lysine), respectively, along with the
water molecule (see above). The methyl group added on H3K9 takes the place of the
hydrogen close to the water molecule, since the other position forms a more stable
hydrogen bond with Tyr-178 and has less space to accommodate the methyl group. This
leads to the reactant complex of di-methylation. Two methyl groups were added to H3K9
and one was added to AdoHcy for the reactant complex for the 3rd methyl transfer (along
with the water). The F281Y mutant was generated simply by changing Phe-281 in wildtype to Tyr with the reactant complexes generated using the similar procedures. The
systems of SET7/9 and its Y305F mutant for the 3rd methyl transfer were generated in a
similar way as in the case of DIM-5, using the structures in our earlier simulations on
SET7/9 8.
The initial structures for the entire stochastic boundary system were optimized by
steepest descent (SD) method and adopted basis Newton-Raphson (ABNR) method. The
systems were gradually heated from 50.0 to 283.15 K in 50 ps and equilibrated at 283.15
K for 500 ps. A 1-fs time step was used for integration of the equation of motion, and the
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coordinates were saved every 50 fs for analyses. 1 ns QM/MM MD simulations were
carried out for each of the reactant and product complexes of the 1st, 2nd and 3rd methyl
transfers after 500-ps of equilibration was performed. As discussed in the previous
studies and mentioned earlier in this paper, the SN2 methyl transfer from AdoMet to K9,
K9me or K9(me)2 would presumably be more efficient if the S-CH3 group of AdoMet is
well aligned with the lone pair of electrons of Nξ in the reactant complex with a small θ
angle and relatively short CM-Nξ distance.8-9,

12-14, 24

Therefore, during the MD

simulations, we monitored the distributions of r(CM-Nξ) and θ, which was defined as the
angel between the direction of the CM-Sδ bond (r2) and the direction of the electron lone
pair (r1), (see Figure VII-1C). This allows us to estimate the free energy contribution to
the activation barrier due to the formation of the reactive substrate complexes (or near
attack conformers). The free energy curves as functions of r(CM-Nξ) and θ in the reactant
complexes were generated from the probability densities ρ[r(CM-Nξ)] and ρ(θ) based on
the trajectories of the 1-ns MD simulations and following formula:21
W(ξ) = - kBT ln ρ(ξ).
Here kB is the Boltzmann’s constant, T is the temperature (283.15 K), and ξ is
r(CM-Nξ) or θ.
The umbrella sampling method22 implemented in the CHARMM program along
with the Weighted Histogram Analysis Method (WHAM) 23 was applied to determine the
change of the free energy (potential of mean force) as a function of the reaction
coordinate for the methyl transfer from AdoMet to H3-K9, H3-K9me or H3-K9(me)2 in
each case. The reaction coordinate is defined as a linear combination of r(CM-Nξ) and

Chapter VII

163

r(CM-Sδ) [i.e., R = r(CM-Sδ) – r(CM-Nξ)]. )]. Each methylation process was described by
twenty windows, in which 50 ps productive runs were performed after 20 ps
equilibrations. The force constants of the harmonic biasing potentials used in the PMF
simulations were 50 to 500 kcal·mol–1·Å–2. The free energy profiles for the reverse
methyl-transfer processes (methyl transfer from methylated lysine to AdoHcy) were also
performed afterward, most of which are almost identical to the corresponding free energy
profiles for the methylation process (methyl transfer from AdoMet to lysine/methyllysine/dimethyl-lysine).

Results
Methyl transfers in wild type DIM-5
The average structures of the active sites of the reactant complexes of wild type
DIM-5 for the 1st, 2nd, and 3rd methyl transfers are compared in Figure VII-2A-C. It can
be seen from Figure VII-2A-C that the lone pair of electrons on Nζ of the target
lysine/methyl lysine and the methyl group of AdoMet are well aligned in all the three
structures. An average distance of 3.0Å between Nξ and CM were obtained for these three
reactant complexes. The oxygen atoms of the carbonyls of Val203, Arg238, Ile240 and
that of the Tyr283 side chain interact with the methyl group of AdoMet, and it has been
proposed that such C-H…O hydrogen bonds may play a role in the catalysis by fixing the
methyl group toward the lone pair of electrons on Nξ.
The average structure of the reactant complex for the 1st methyl transfer (Figure
VII-2A) is similar to the X-ray structure of DIM-5 (PDB code: 1PEG) 6b; the RMSD was
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calculated to be 0.6Å for all the atoms within 5Å from the reaction center (CM). For this
structure, the position and the orientation of the ε-amino group seems to be fixed by its
hydrogen bond with Tyr178, indicating an important role of Tyr178 in the catalysis.6 The
activity of DIM-5 was indeed found to be complete lost and dramatically reduced as a
result of Y178→V and F mutation, respectively.6b There is a water molecule (W1) in
Figure 2A-C. This water molecule was built manually by comparing DIM-5 with the
structures of SET7/9 (PDB code: 1O9S)

5b

and LSMT (PDB code: 1OZV)5h, as the

crystal structure of DIM-5 did not show this water molecule. Figure 2A-C shows that one
of the important differences in the three average structures of reactant complexes is the
position of W1. As shown in Figure VII-2A, in the reactant complex of DIM-5·LysNζH2·AdoMet W1 forms hydrogen bonds with the carbonyl groups of Ile240 and Thr237
(not shown) and the ε-amino group of H3K9 (similar to the case of SET7/9). These three
hydrogen bonds fix the position of W1 at the active site and may contribute to the
stabilization of the position of H3K9 as well. In the reactant complex of DIM-5·LysNζ(Me)H·AdoMet, one hydrogen on Nξ still forms a stable hydrogen bond with Tyr178,
while the other one has been replaced by a methyl group. The water molecule W1 lost its
hydrogen bonds with both the lysine ε-amino group and the carbonyl of Ile240. W1
moves away from its position in DIM-5·Lys-NζH2·AdoMet with an average distance
between W1 oxygen and Nξ increased from 3.2Å to 4.9Å. In the reactant complex of
DIM-5·Lys-Nζ(Me)2·AdoMet, the ε-amino group of the target lysine has both of its two
hydrogen atoms replaced by methyl groups. It is therefore unable to hydrogen-bond to
Tyr178, and the methyl groups seem to form hydrophobic interactions with the aromatic
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rings of Tyr178, Tyr283 and Phe281. These hydrophobic interactions may help to fix the
position of the ε-amino group so that the lone pair of electrons on Nζ can be well aligned
with the methyl group of AdoMet for the efficient methyl transfer. W1 has been pushed
away from the active site (about 8Å to Nζ) and forms new hydrogen bonds with the
carbonyl groups of Asp176 and Leu265.
Consistent to the average structures of the three reactant complexes, the two
dimensional plots of r(CM…Nζ) and θ distributions (see the definitions of the two
parameters in method) exhibit similar patterns. All of the three reactant complexes have
r(CM…Nζ) concentrated in 2.5 to 3.5Å and θ concentrated in 0 to 60 degree. (Figure VII2D-F) These patterns suggest that the active site in each case adopts a reactive structure
with a good alignment of the methyl group with the electron lone pair on Nξ. The results
therefore show that the wild type DIM-5 may efficiently transfer all the 1st, 2nd, and 3rd
methyl groups from AdoMet to lysine 9, which is consistent to the experimental result
that wild type DIM-5 mainly produces trimethyl-lysine. The product specificity of wild
type DIM-5 as a trimethylase was further confirmed by the free energy simulations (see
below).

Methyl transfers in F281Y mutant of DIM-5
For the reactant complexes of DIM-5 F281Y mutant, the average structure of the
active site for the 3rd methyl transfer is very different from those for the 1st, 2nd transfers
(Figure VII-3A-C). In the reactant complexes for the 1st and 2nd methyl transfers, the
positions of the target H3K9 and H3K9me relative to the methyl group of AdoMet are
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similar to those in the WT complexes. The average distances between Nζ and CM are both
about 3.0Å, with the lone pair of electrons on Nζ well aligned to the methyl group to be
transferred. Consistent to the average structures, the two dimensional plots of r(CM…Nζ)
and θ distributions both have the distributions concentrated in the area of 2.5 to 3.5Å and
0 to 70 degree (Figure VII-3D, E). In contrast, the reactant complex for the 3rd methyl
transfer has an much larger average distance of r(CM…Nζ) as 4.6Å (Figure VII-3C). The
amino group of H3K9(me)2 undergoes large fluctuations in both the position and the
orientation. The two methyl groups on Nζ rotate constantly with no stable interactions
formed with surrounding residues. The two dimensional plots of r(CM…Nζ) and θ
distributions have a much dispersed pattern, with r(CM…Nζ) ranging from 3 to 6Å and θ
to all the angles (Figure VII-3F).
Although the reactant complexes for 1st and 2nd methyl transfers have similar
r(CM…Nζ) and θ distributions, the stabilization of the amino groups seems a little
different in the two complexes. Similar to the stabilization of H3K9 in the wild type
DIM-5, one hydrogen atom on Nζ forms stable hydrogen bonds with the side chain of
Tyr178; the other hydrogen may form a hydrogen bond with the side chain of Tyr281 or
the oxygen of W1. For the reactant complex of the 2nd methyl transfer, the reactant
complex has 90% chance to have a structure in which H3K9me forms a hydrogen bond
with oxygen of Val203 carbonyl, instead of to Tyr178 (which was observed in the
reactant complex of WT-DIM-5·Lys-Nζ(Me)H·AdoMet). The average distance between
Nζ and the W1 oxygen is increased from 3.6Å in the 1st methyl transfer reactant complex
to 4.5Å in the 2nd methyl transfer reactant complex.
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The 3rd methyl transfers in wild type and Y305F mutant of SET7/9
The correlation between the product specificity and the reactant complex
structures are also observed in our simulations on the wild type and Y305F mutant of
SET7/9, a mono-methylase. The wild type SET7/9 reactant complex only has reactive
structures for the 1st methyl transfer. The two dimensional plot has r(CM…Nζ) and θ
concentrated within 2.5 to 3.5Å and 0 to 60 degree, respectively.8 Whereas in the reactant
complex for 2nd methyl transfer, the methylated ε-amino group of H3K9me is quite
flexible, corresponding to a dispersed distribution of r(CM…Nζ) and θ between 3 to 5.5Å
and 0 to 120 degree, respectively.8 The reactant complex for the 3rd methyl transfer has
lower flexibility in the position and orientation of H3K9(me)2 group, but it is “stabilized”
at an unfavorable conformation for the methyl transfer. The average distance of
r(CM…Nζ) is as long as 4.3Å, and the lone pair of electrons on Nζ is almost perpendicular
to the direction of the methyl group to be transferred. (Figure VII-4A) Correspondingly,
the two dimensional plot shows a concentrated pattern with r(CM…Nζ) between 3.5 to 5Å
and θ around 90 degree. (Figure VII-4C)
In the simulations of SET7/9 Y305F mutant, the reactant complexes for both the
1st methyl transfer and the 2nd methyl transfer have a reactive average structure similar to
the one for 1st methyl transfer in wild type SET7/9. The average distances r(CM…Nζ) are
2.9 and 3.2Å, respectively, and the lone pair of electrons on Nξ is well aligned toward the
methyl group to be transferred. Correspondingly, the free energy simulations obtained
comparable low barriers as about 15kcal/mol for both the 1st and the 2nd methyl
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transfers.8 However, the structure of the reactant complex for the 3rd methyl transfer is
quite distinct. Although the conformation of the ε-amino group of H3K9(me)2 is relative
stable, the methyl group of AdoMet undergoes a movement deviating from the active site.
The distance of r(CM…Nζ) fluctuates from 4.5 to 7Å, averaged at 5.6Å. And the lone pair
of electrons on Nξ points away from the methyl group, resulting in the angle θ as 90 to
150 degree. This result is consistent to the mass spectrometry analysis with only
dimethylated product obtained for Y305F mutant.6b

The relative free energy barriers for methyl transfers: a triplet code for writing
epigenetic marks
An important factor that may control the product specificities of PKMTs is the
relative efficiencies of the 1st, 2nd, and 3rd methyl transfers. To reflect such relative
efficiencies of PKMTs for the 1st, 2nd, and 3rd methyl transfers, we designed a triplet code
(0, Δ2-1, Δ3-1) to present the differences in free energy barriers for the methyl transfers.
The first parameter of the triplet code is the free energy barrier for the 1st methyl transfer
and set to be the zero. The second (Δ2-1) and the third (Δ3-1) numbers of the triplet code
are the difference in free energy barriers for the 2nd and the 3rd methyl transfers compared
to the barrier for the 1st methyl transfer, respectively. In this way, the triplet code can
clearly reflect the different efficiency of a PKMT to transfer the 1st, 2nd, and 3rd methyl
groups to the target lysine/methyl lysine.
Since the free energy barrier for the 3rd methyl transfer in wild type DIM-5 is
1kcal/mol lower than those for the 1st and 2nd methyl transfers (which have the same
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barriers), the triplet code for the three methyl transfers can be written as (0, 0, -1) for wild
type DIM-5 (Figure VII-5A). This triplet code suggests a comparable or even higher
activity for the 2nd and 3rd methyl transfers than the 1st methyl transfer, consistent with the
product specificity of DIM-5 as a trimethylase.6b At the same time, with the free energy
barriers of the 1st, 2nd, and 3rd methyl transfers in F281 mutant of Dim-5 as 15, 18 and 20
kcal/mol, the triplet code for DIM-5 F281 mutant can be written as (0, 3, 5), suggesting
increased free energy barriers and decreased activities in 2nd and 3rd methyl transfers
(Figure VII-5B). The 3 kcal/mol difference for the 2nd methyl transfer compared to that
for the 1st methyl transfer may not prohibit the production of dimethylated lysine, but
would slow down the production. The 5kcal/mol difference for the 3rd methyl transfer is
expected to make the trimethylated product unlikely, consistent with experimental
observations.6b Similarly, the free energy barriers of the methyl transfer in SET7/9 are 18,
23 and 26 kcal/mol, and the triplet code can be written as (0, 5, 8), indicating increased
free energy barriers for 2nd and 3rd methyl transfers too. However, the 5 kcal/mol
difference for 2nd methyl transfer and 8 kcal/mol difference for 3rd methyl transfer make it
very difficult for the further methylation, consistent with the fact that SET7/9 is a monomethylase (Figure VII-5C).

Discussions
Earlier QM/MM simulations has confirmed the methyl transfers in PKMTs to be
an in-line SN2 nucleophilic substitution.8, 9a, 10 The different structures of the reactant
complex may contribute to the different energetic barriers. As shown in Figure VII-2,
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VII-3 and VII-4, the alignment of the lone pair electrons on Nζ to the methyl group of
AdoMet can be reflected by the two dimension plot of r(CM…Nζ) and θ distributions. A
short distance of r(CM…Nζ) about 3.0Å and a small angle of θ lower than 60 degree
generally suggest a good alignment that may facilitate the methyl transfer efficiently. In
contrast, a long distance of r(CM…Nζ) and a dispersed distribution of θ may suggest a
unfavorable alignment for the methyl transfer. Thus, the average structures of reactant
complexes should be related to the efficiencies of the methyl transfers and the product
specificity of the PKMT.
Another way to compare the efficiencies of the different methyl transfers is to
determine their free energy barriers. We proposed a triplet code here that gives the
difference in free energy barriers for the three methyl transfers in the enzyme. We found
that the triplet code (0, 0, -1) obtained from simulations on DIM-5 is consistent to the
experimental result of Tyr/Phe switch for the product specificity of DIM-5. In other
words, the further methylations are comparable or even easier than the 1st methylation.
Considering that the multi-methyl transfers by the SET domain PKMTs is a processive
instead of a distributive process (which has been suggested by evidences from the
catalytic kinetics and product analyses14), the products would expect to be the
trimethylated final product, instead of the monomethylated or dimethylated
intermediates. This is consistent with the fact that DIM-5 is a tri-methylase. In contrast,
our simulation results are also consistent to the experimental result that the PheÆTyr
mutation at residue 281 switches DIM-5 from a tri-methylase into a mono-/di- methylase.
The concentrated distributions of r(CM…Nζ) and θ in the reactant complex for 1st and 2nd

Chapter VII

171

methyl transfers suggested the potential activity for F281Y mutant to transfer one or two
methyl groups to H3K9, whereas the dispersed distributions of r(CM…Nζ) and θ in a
broad area suggested an extra cost in energy to fix the electron lone pair on Nζ and
methyl group of AdoMet in the reactive configurations. (Figure VII-3) Correspondingly,
the free energy simulations resulted in a triplet code for DIM-5 F281Y mutant of (0, 3, 5)
(Figure VII-5B). As indicated by the second number in the triplet code, the barrier for the
2nd methyl transfer is about 3 kcal/mol higher than that of the 1st methyl transfer. This
may not entirely prevent the production of dimethylated lysine, but can lower the activity
for 2nd methyl transfer significantly, consistent with experimental observations.6b The
third number of the triplet code indicates that over 5 kca/mol more energy is needed for
the 3rd methyl transfer. Therefore, an even lower activity for the 3rd methyl transfer is
expected, which is also consistent with the experimental result.6b
The correlation of the product specificity with the reactant complexes structures
and the triplet code for the free energy barrier differences is also observed in the
simulations of another PKMT, the monomethylase SET7/9. Consistent with the product
specificity of wild type SET7/9, the two dimensional plot of r(CM…Nζ) and θ
distributions only suggest a favorable structure for the SN2 reaction in the reactant
complex for 1st methyl transfer.8 The structure in the reactant complex for the 2nd methyl
transfer generates a quite dispersed distribution in r(CM…Nζ) and θ,8 and the plot of
r(CM…Nζ) and θ in the reactant complex for the 3rd methyl transfer suggest the ε-amino
group to be stabilized at unfavorable position for the methyl transfer (Figure VII-4).
Correspondingly, the triplet code (0, 5, 8) suggests over 5 kcal/mol additional energy is
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needed for the 2nd methyl transfer and over 8kcal/mol additional energy is required for
the 3rd methyl transfer. The Y305F mutant of SET7/9 switches the product specificity of
wild-type into a dimethylase as demonstrated experimentally.6b Consistent with this, the
average structures of reactant complexes for the 1st and the 2nd methyl transfers have
favorable reactive configurations,8 and the reactant complex for the 3rd methyl transfer
has the dispersed and unfavorable distributions of r(CM…Nζ) and θ (Figure VII-4). In
summary, both the r(CM…Nζ) and θ distributions and the triplet code for the difference in
free energy barriers can be used to understand and predict the product specificity for
SET7/9 as well.

Conclusions
The quantum mechanical/molecular mechanical (QM/MM) molecular dynamics
(MD) simulations on the 1st, 2nd and 3rd methyl transfers from AdoMet to the target
lysine/methyl lysine in the N. crassa DIM-5 (a trimethylase) and human SET7/9 as well
as their mutants suggest the existence of correlations between product specificity and the
population of r(CM…Nζ) and θ distributions and the relative free energy barriers for
methyl transfers. The difference in free energy barriers for methyl transfers are
summarized into a triplet code, which can pretty well explain the product specificity
switch by F281Y mutation in DIM-5 and Y305F mutant in SET7/9.
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Appendix
Figure VII-1. The methyl transfers in PKMTs
(A) Lysine residue has three protons, and each of them may be replaced by a methyl group. Therefore, the
lysine residue may be mono-, di- or tri-methylated by PKMTs. (B) Hypothetical processive methylation
process catalyzed by the tri-methylase DIM-5. The basic form of the lysine or methyl lysine is the
nucleophile, and the lone pair of electrons on its Nζ is the site where additional methyl group can be added.
Therefore, the further deprotonation of Lys-Nζ(Me)H2+ (Lys-Nζ(Me)2H+) is required before the 2nd (3rd)
methyl group can be transferred from AdoMet to the methyl lysine (dimethyl lysine). Two of the possible
ways by which the enzymes may control the product specificity are: (1) limiting the further methylation
through the increase of the activation barrier8-9 of methyl transfers and (2) stopping the deprotonation
process.10 (C) The definition of the structural parameters for monitoring the relative orientation of AdoMet
and H3K9me [H3K9 and H3K9(me)2] in the reactant complex. The efficiency of the methyl transfer may
be related to the distributions of r(CM…Nζ) and θ in the reactant complexes. θ is defined as the angle
between the two vectors r1 and r2. Here r1 is the direction of the lone pair of electrons on Nζ and r2 is the
vector pointing from CM to Sδ. The reaction coordinate for calculating the free energy profiles for the
methyl transfers is R = r(CM…Sδ) – r(CM…Nζ).
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Figure VII-2. The average structures and r(CM…Nζ)/θ distributions of the reactant
complexes for methyl transfers in wild type DIM-5
(A) The average active-site structure of the reactant complex for the 1st methyl transfer in DIM-5 (DIM-5
complexed with AdoMet and histone H3K9 peptide) obtained from the QM/MM MD simulations. DIM-5
is shown in balls and sticks, and AdoMet and the H3K9 sidechain are in sticks. Hydrogen bonds are
indicated by red dotted lines, and carbon-oxygen hydrogen bonds involving the methyl group are shown in
green dotted lines. The distances related to the reactant coordinate are also shown. (B) The average
structure of the reactant complex for the 2nd methyl transfer (DIM-5 complexed with AdoMet and
H3H9me). The hydrogen atoms of the methyl group on H3K9me are not shown for clarity. (C) The average
structure of the reactant complex for the 3rd methyl transfer [DIM-5 complexed with AdoMet and
H3K9(me)2]. The hydrogen atoms of the methyl groups on H3K9(me)2 are not shown for clarity. (D) Two
dimensional plot of r(CM…Nζ) and θ distributions from the 1ns QM/MM MD simulations of the reactant
complex for the 1st methyl transfer in DIM-5. (E) Two dimensional plot of r(CM…Nζ) and θ distributions of
the reactant complex for

the 2nd methyl transfer. (F) Two dimensional plot of r(CM…Nζ) and θ

distributions of the reactant complex for the 3rd methyl transfer.
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Figure VII-3. The average structures and r(CM…Nζ)/θ distributions of the reactant
complexes for methyl transfers in DIM-5 F281Y mutant
(A) The average active-site structure of the reactant complex for the 1st methyl transfer in F281Y (F281Y
complexed with AdoMet and histone H3K9 peptide). (B) The average structure of the reactant complex for
the 2nd methyl transfer in F281Y (F281Y complexed with AdoMet and H3H9me). The hydrogen atoms of
the methyl group on H3K9me are not shown for clarity. (C) The average structure of the reactant complex
for the 3rd methyl transfer in F281Y [F281Y complexed with AdoMet and H3K9(me)2]. The hydrogen
atoms of the methyl groups on H3K9(me)2 are not shown for clarity. (D) Two dimensional plot of
r(CM…Nζ) and θ distributions of the reactant complex for the 1st methyl transfer in F281Y. (E) Two
dimensional plot of r(CM…Nζ) and θ distributions of the reactant complex for the 2nd methyl transfer. (F)
Two dimensional plot of r(CM…Nζ) and θ distributions of the reactant complex for the 3rd methyl transfer.
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Figure VII-4 The average structures and r(CM…Nζ)/θ distributions of the reactant
complexes for the 3rd methyl transfers in the wild type and Y305F mutant of SET7/9
(A) The average active-site structure of the reactant complex for the 3rd methyl transfer in wild type SET7/9
[SET7/9 complexed with AdoMet and H3K4(me)2] (B) The average active-site structure of the reactant
complex for the 3rd methyl transfer in the Y305F mutant of SET7/9 [Y305F complexed with AdoMet and
H3K4(me)2]. (C) Two dimensional plot of r(CM…Nζ) and θ distributions in the reactant complex for the 3rd
methyl transfer of wild type SET7/9. (D) Two dimensional plot of r(CM…Nζ) and θ distributions in the
reactant complex for the 3rd methyl transfer of Y305F mutant.
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Figure VII-5. The free energy changes for the methyl transfers in the wild type and
the F281Y mutant of DIM-5, as well as in wild type SET7/9
(A) The free energy (potential of mean force) changes for the 1st, 2nd and 3rd methyl transfers from AdoMet
to H3-K9, H3-K9me and H3-K9(me)2, respectively, as functions of the reaction coordinate [R = r(CM…Sδ)
– r(CM…Nζ)] in wild-type DIM-5. The 1st methyl transfer: blue and solid line; the 2nd methyl transfer: red
and dashed line; the 3rd methyl transfer: green and dotted line. The relative free energy barriers can be
represented by a triplet code (0, Δ2-1, Δ3-1) = (0, 0, -1). Here Δ2-1 and Δ3-1 are the changes of the free energy
barriers from the 1st to the 2nd methyl transfer (about 0 kcal/mol) and from the 1st to the 3rd methyl transfer
(about -1kcal/mol), respectively. The free energy barrier for the 1st methyl transfer is default to be zero in
this triplet. (B) The free energy changes for the 1st, 2nd and 3rd methyl transfers as functions of the reaction
coordinate in the F281Y mutant. The 1st methyl transfer: blue and solid line; the 2nd methyl transfer: red
and dashed line; the 3rd methyl transfer: green and dotted line. The triplet code for the relative difference in
activation barriers is (0, Δ2-1, Δ3-1) = (0, 3, 5). (C) The free energy changes for the 1st, 2nd and 3rd methyl
transfers as functions of the reaction coordinate in wild-type SET7/9. The 1st methyl transfer: black and
solid line; the 2nd methyl transfer: red and dotted line; the 3rd methyl transfer: blue and dashed line. The
triplet code for the relative difference in activation barriers is (0, Δ2-1, Δ3-1) = (0, 5, 8).
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Chapter VIII
Conclusions and future directions
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The dynamic features of enzymes in solution have been gradually recognized as
an important factor for enzyme activities and specificities. However, the dynamic
motions such as proton transfers, side chain movements and conformational changes of
subdomains can not be easily reflected in the high resolution structures determined by Xray crystallography. With the developments in NMR and many other methods, the
conformational ensembles of enzyme structure can be observed at atomic level, but the
changes of interactions and energies during the dynamic motions are still difficult to
determine. Complementary to conventional structural analysis, computational simulations
have the advantage of monitoring the dynamic motions in proteins or enzymes. More
importantly, the energetic changes related to these motions can be calculated using
computer programs.
In this dissertation, the quantum mechanical/molecular mechanical (QM/MM)
molecular dynamics (MD) simulations, as well as free energy simulations using the
umbrella sampling method and the weighted histogram analysis method (WHAM)
program, were applied to the studies on the bindings of transition state analogue (TSA) to
cytidine deaminase (CDA) and yeast cytosine deaminase (yCD), the catalytic mechanism
of kumamolisin-As, as well as the product specificities of two protein lysine
methyltransferases (PKMTs), DIM-5 and SET7/9.
In the simulations of the TSA bindings of zebularine 3, 4-hydrate (ZEB-H2O) to
CDA and of 4-[R]-hydroxyl-3,4-dihydropyrimidine (DHP) to yCD, proton transfers were
observed between the TSA and a catalytic Glu residue (Glu104 in CDA and Glu64 in
yCD). The absence of this critical Glu residue destabilizes the TSA at the active site. The
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TSA of CDA, ZEB-H2O was rapidly dehydrated at the active site of E104A mutant. In
addition, the stabilization of the tetrahedral TSA by the Glu residue seems to be attributed
to a proton transfer from the TSA to the Glu, instead of a hydrogen bond between the
hydroxyl and the negative carboxylate of the Glu residue. In both CDA and yCD, free
energy simulations estimated about 8kcal/mol lower energy for the tetrahedral TSA
complex with this proton transferred than the one with the proton not transferred.
The general acid-base mechanism was also observed in the stabilization of the
tetrahedral intermediate by Asp164 during the acylation of kumamolisin-As. Asp164 acts
as a general acid to protonate the negative oxygen of the tetrahedral intermediate formed
by the nucleophilic attack of Ser278. Then this residue acts as a general base and accepts
the proton back from the tetrahedral intermediate during the formation of the acylenzyme. In addition to the stabilization by Asp164, Glue78 aslo acts as a general acidbase to mediate the proton transfer from Ser278 to the nitrogen of the scissile peptide
bond. Moreover, dynamic substrate-assisted catalysis (DSAC) involving the His of the
substrate at the P1 site was proposed to be triggered by the bond breaking and making
events during the acylation, expecially the protonation/deprotonation of the Asp164
carboxylate. It was suggested that the back and forth movements of the His sidechain
between the hydrogen bond with carbonyl of Pro at P2 site and the salt bridge with Oδ2 of
Asp164 may contribute to the transition state stabilizations and substrate specificity of
kumamolisin-As.
The origin of the product specificities of PKMTs was studied by comparison of
QM/MM MD simulations on the first, second and third methyl transfers in the
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trimethylase DIM5 and the monomethylase SET7/9, as well as in two of their mutant
forms of the enzymes. The product specificities of the enzymes can be well explained by
the population distributions of r(CM…Nζ) and the angle θ (the distance for Nζ to attack
the methyl group and the angle between the orientation of the electron lone pair on Nζ
relative to the CM-Sδ bond) in the dynamic conformational ensemble of the well-aligned
reactant structures, as well as the relative free energy barriers for the methyl transfers.
Based on the relative diffierences in the free energy barriers for the three methyl transfers,
a triplet code was proposed in the determination of product specificities of PKMTs.
In summary, our results of QM/MM MD simulations on different enzymes (CDA,
yCD, kumamolisin-As and PKMTs) support the importance of dynamics in enzymatic
catalysis. In the first three cases, we reported the importance of the proton transfers to
lower the reaction barriers and to stabilize the tetrahedral intermediates or transition state
analogues at the active sites. This is in contrast with the previous proposals based on the
structural analyses of these enzymes, in which the hydrogen bonding interactions were
the key reason for the stabilizations. In the case of kumamolisin-As, we also proposed
DSAC, in which the conformational changes of the substrate groups and formation of
alternative interactions may lower the energetic barriers at different stages of the reaction
cycle. This is an important development for traditional SAC studies, which focus on the
contributions from well positioned substrate groups without involving conformational
changes. In the case of PKMTs, we designed a triplet code reflecting the differences in
the energetic barriers for the methyl transfers catalyzed by PKMTs and used this triplet
code to explain the product specificities of PKMTs and their mutants.
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Based on our current simulation conditions, future studies in QM/MM MD
simulations may still focus on reactions in local regions. For examples, we may further
study the binding of other TSAs on CDA, such as 3,4,5,6-tetrahydrouridine (THU), so as
to confirm the importance of the proton transfer to Glu. We are also interested in the role
of the critical Glu in catalytic processes of cytidine deamination in CDA and cytosine
deamination in yCD, which was suggested as a general acid-base proton shuttle both
during the nucleophilic attack and in the formation of product. We may continue our
studies on kumamolisin-As in the process of deacylation and attemp to determine the rate
limiting step of the reaction cycle. The collaboration between the proton transfers is of
great interest also. We may further our studies on PKMTs in many aspects. For instance,
the Tyr245 mutants of SET7/9 involve another residue critical to the methyltransferases
activity of PKMTs. The Y245F mutant of SET7/9 and the corresponding Y178F mutant
of DIM-5 both have dramatically lowered activities but their product specificities are not
changed. However, it is quite interesting that the Y245A mutant of SET7/9 has higher
efficiencies for the second and third methyl transfers compared to the first methyl transfer.
Monitoring of the reactant complexes before the first, second and third methyl transfers
in the Y245A mutant of SET7/9 may help to explain this difference in efficiency of
methyl transfers. The product specificities of other PKMTs, such as the monomethylase
SET8 may also be simulated. What is more, we are also interested in studies of the
deprotonation, such as the possible role of Tyr335 as suggested in our earlier works (Ref.
8 of chapter VII). Finally, we would like to expand our computational simulations to the
studies of other enzymatic reactions and catalysis.
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